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Abstract 
Endophytic fungi and bacteria are microorganisms harbored in the plant tissues without 
causing any disease. They are proven to be a rich source of new anticancer and 
antimicrobial compounds as well as clinically valuable agents identified from plant 
materials. However, recent research encounters enormous difficulties, which reveals 
that endophytic systems are complex ecological communities maintained by inter-
species and inter-kingdom interactions, including chemical crosstalk. Consequently, 
investigating the chemical basis of these interactions is essential to interpret the 
interaction among endophytes and host plant, and exploit the true potential of 
endophytes. Based on metabolite screening of endophytes from several Chinese 
traditional medicinal plants with antibacterial related uses, endophytic fungi and bacteria 
isolated from two plants Narcissus tazetta and Buxus sinica were selected for the 
investigation in this thesis. 
From an endophytic fungus, Fusarium solani N06, isolated from a bulb of N. tazetta, 
nine new hexacyclopeptides (1−9) were discovered as crosstalk molecules between it 
and another endophytic bacterium, Achromobacter xylosoxidans N12B, from the same 
tissue. In the matrix-assisted laser desorption ionization imaging high-resolution mass 
spectrometry (MALDI-imaging-HRMS) experiments, the secretion of these compounds 
from this F. solani N06 and the accumulation towards A. xylosoxidans N12B was 
visualized on the border between the fungus and bacterium. From the optimized culture 
of F. solani N06, sufficient extracts of these hexacyclopeptides were analyzed by liquid 
chromatography-multiple stage mass spectrometry (LC-MSn) and their sequence was 
identified to be cyclo((Hyp or Dhp)-Xle-Xle-(Ala or Val)-Thr-Xle) (Dhp: dehydroproline) 
based on the characteristic a, b, or y ions in MSn spectra. The phenomenon that 
coexisting endophytes utilize new signal molecules suggests that they have developed 
communication strategies to survive and function in their distinct ecological niches. 
Four new compounds, colletotrichones A−D (10−13) and one known compound 
chermesinone B (14a) were isolated from the fermented rice medium of an endophytic 
fungus Colletotrichum sp. BS4, which was isolated from the leaves of B sinica. With 
comprehensive spectroscopic methods including 1D and 2D NMR, HRMS, ECD spectra, 
UV, and IR as well as single crystal X-ray diffraction and quantum chemistry calculation, 
their structures were identified to be azaphilones sharing a 3,6a-dimethyl-9-(2-
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methylbutanoyl)-9H-furo[2,3-h]isochromene-6,8-dione core structure. In the antibacterial 
bioassay against two environmental strains of Escherichia coli and Bacillus subtilis, as 
well as two human pathogenic clinical strains Staphylococcus aureus and Pseudomonas 
aeruginosa, colletotrichone A (10) exhibited extraordinary activity against E. coli and B. 
subtilis, with a minimum inhibitory concentration lower than positive controls 
streptomycin and gentamicin. In the cytotoxic assay, interestingly, compounds 10−12, 
and 14a showed slight cytotoxicity at high concentration (100 µM). Furthermore, the 
spatial distribution and localization of the compounds produced by the endophyte were 
visualized by MALDI-imaging-HRMS, which revealed their plausible ecological functions.  
In the investigation of endophytic fungus Phyllosticta capitalensis harbored in the leaves 
of B. sinica, two new lactam-fused 4-pyrones (15, 16) were discovered in static PDB 
fermentation. Their structures were elucidated by 1D and 2D NMR, LC-MSn, DFT 13C 
NMR calculation and chemical reaction. By 16S rRNA analyses, an endosymbiotic 
bacterium Herbaspirillum sp. was discovered in the hyphae of P. capitalensis, which was 
not cultivable in ordinary culturing condition. The PKS/NRPS gene cluster analyses 
showed these two compounds were biosynthesized by fungal PKS and bacterial NRPS. 
This cross-species cooperation of secondary metabolites production unveiled another 
level of interaction between the endophytic bacterium and fungus. 
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Zusammenfassung 
Als endophytische Pilze und Bakterien werden die im Pflanzenkörper eingelagerten 
Mikroorganismen bezeichnet, welche keine Schäden oder Krankenheitssymptome für 
das sie umgebende Pflanzengewebe hervorrufen. Studien zeigen auf, dass Endophyten 
eine reiche Quelle für die Gewinnung neuer Verbindungen mit antimikrobiellen 
Eigenschaften als auch neuer potenziell als Antikrebsmittel in Frage kommenden 
Verbindungen sind. Einige Verbindungen endophytischen Ursprungs sind bereits 
klinisch etabliert. Die derzeitige Forschung bezüglich der Endophyten ist allerdings mit 
erheblichen Schwierigkeiten verbunden, welche den komplexen Charakter 
endophytischer Gemeinschaften in ihrer ökologischen Umgebung aufzeigen. Die 
Kompexizität wird durch Interaktionen zwischen den unterschiedlichen endophytischen 
Spezies, derenUmgebungen, einschließlich des chemischen „Crosstalks“ begründet. 
Daher sind Untersuchungen betreffend der chemischen Natur der Interaktionen von 
erheblichem Wert, um deren Bedeutung zu interpretieren und somit das gesamte 
Potenzial der Endophyten erschließen zu können. Basierend auf Screenings von 
Metaboliten endophytischen Ursprungs, die von mehreren chinesischen Heilkräutern mit 
traditioneller antibakterieller Verwendung isoliert wurden, fiel die Auswahl auf  
endophytische Pilze und Bakterien der Strauß-Narzisse (Narcissus tazetta) und des 
chinesischen Buchsbaums (Buxus sinica), die in der vorliegenden Arbeit untersucht 
wurden.   
Vom endophytischen Pilz Fusarium solani N06, welcher von der Knolle der N. tazetta 
gewonnen wurde, konnten neun neue Hexazyklopeptide (1−9) als „Crosstalk“-Moleküle 
zwischen diesem Organismus und dem endophytischen Bakterium Achromobacter 
xylosoxidans N12B vom selben Gewebe identifiziert werden. Die Sekretion dieser 
Verbindungen vom F. solani N06 konnte mit Hilfe hochaufgelöster bildgebender Matrix-
assistierter Laser Desorption/Ionisation (MALDI-imaging-HRMS) Experimente 
visualisiert werden. Es zeigte sich dabei eine Akkumulation der Stoffe im Grenzbereich 
zwischen dem sekretierenden Pilz und dem Bakterium A. xylosoxidans N12B in 
Richtung des Bakteriums. Von der optimierten F. solani N06 Kultur konnten die 
Hexazyklopeptide gewonnen und über Flüssigchromatographie Massenspektrometrie 
(LC-MSn) analysiert werden. Ihre Sequenz wurde dabei basierend auf charakteristischen 
Ionen a, b, oder y in den MSn Spektren als zyklo((Hyp oder Dhp)-Xle-Xle(Ala or Val)-
Zusammenfassung 
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Thr-Xle) (Dhp: Dehydroprolin) identifiziert werden. Diese Erkenntnisse deuten darauf hin, 
dass koexistierende Endophyten Kommunikationsstrategien entwickelt haben, um in 
ihren speziellen ökologischen Nischen zu funktionieren und zuüberleben. 
Vier neue Verbindungen, die Colletotrichone A−D (10−13), und eine bekannte Substanz, 
das Chermisonon B (14a), konnten vom fermentierten Reismedium des von den Blättern 
vom B. sinica isolierten endophytischen Pilzes Colletotrichum sp. BS4 erhalten werden. 
Durch Einsatz umfassender spektroskopischer Methoden, u.a. der 1D und 2D NMR, 
HRMS, ECD, UV und IR Techniken als auch der Einkristallröntgenstrukturanalyse sowie 
durch quantenchemische Berechnungen konnten ihre Strukturen als Azophilone, die 
sich ein 3,6a-Dimethyl-9-(2-methylbutanoyl)-9H-furo[2,3-h]isochromen-6,8-dion 
Kerngerüst teilen, aufgeklärt werden. Durch antibakteriellen Biotests wurde die 
außergewöhnlich hohe Aktivität  des Colletotrichon A (10) gegen E. coli and B. subtilis 
festgestellt. Verglichen mit den Kontrollsubstanzen Streptomycin und Gentamycin 
besitzt dieses eine niedrigere minimale Hemm-Konzentration. Darüberhinaus konnte für 
die Substanzen 10−14 keine signifikante Zytotoxizität festgestellt werden. Selbst bei 
Applikation hoher Konzentrationen (100 µM) zeigte sich nur eine geringfügige 
Zytotoxizität. Außerdem wurde die räumliche Verteilung dieser von den Endophyten 
produzierten Verbindungen mittels bildgebender MALDI-HRMS gezeigt, was 
Rückschlüsse auf deren ökologischen Funktionen erlaubt.   
Im Extrakt der statischen PDB Fermentierung vom endophytischen Pilz Phyllosticta 
capitalensis, welche in den Blättern des B. sinica zu finden ist, konnten zwei neue 
Lactam-Einheiten enthaltende 4-Pyrone (15, 16) entdeckt werden. Die 
Strukturaufklärung erfolgte mit Hilfe der 1D and 2D NMR und LC-MSn Techniken und 
DFT 13C NMR Berechnungen sowie durch chemische Modifikationen. Durch die 16S 
rRNA Analyse konnte das endosymbiotische Bakterium Herbaspirillum sp. in den 
Hyphen der P. capitalensis aufgefunden werden. Dieses ist jedoch unter gewöhnlichen 
Kulturbedingungen nicht kultivierbar. Die PKS/NRPS Gen-Clusteranalyse bewies, dass 
15 und 16 durch das fungale PKS und bakterielle NRPS biosynthetisiert werden. Diese 
„Cross Species Cooperation“ zur gemeinsamen Produktion von Sekundärmetaboliten 
offenbart eine andere, neue Stufe innerhalb möglicher Interaktionen zwischen 
endophytischen Bakterien und Pilzen. 
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1. Introduction 
1.1 Plants, “bustling” niches of microbes 
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Fungi and bacteria used to be well-known as unconscious and selfish decomposers or 
pathogens leading saprobiontic or parasitic lifestyle, except those photosynthetic 
bacteria. In the ecological systems, however, fungi and bacteria are actually able to 
collaborate with other organisms, utilizing highly organized strategies. For example, 
lichen is a typical symbiotic organism consisting of supporting fungi and 
photoautotrophic algae or cyanobacteria (or both).1  
Plants, the major primary producers in most terrestrial ecosystems, are also bustling 
habitats of microbes. They have probably been colonizing living plants since the 
appearance of the most primitive plants.2 Microbes and plants are likely to have been 
co-evolving for more than 400 million years and generating complex ecological 
communities.2–4 Overwhelming evidence shows that microbes could not be only 
sojourners or parasites associated with plants but also beneficial partners playing 
essential roles in the ecological systems.2–4  
The surface of global phyllosphere is more than 1 billion km2, and it is not surprising that 
plants provided vast habitat above the ground for countless epiphytic microbes.5 
Although these microbes are exposed to the atmospheric environment and anti-
microbes compounds released by plants, with limited water and nutrients supply,5,6 they 
have adapted on the surface of plants with multiple strategies. For example, 
Pseudomonas syringae is capable of producing coronatine7 or syringolin A8 to 
counteract the closure of stomata.5 And mossed epiphytic bacterium Methylobacterium 
funariae interact with plants by secreting phytohormones.7  
In the middle of the nineteenth century, scientists had discovered mycorrhizae, which 
are symbiotic fungi associated with vascular plant roots.9 Moreover, the investigation of 
biofertilizers revealed the hidden communities of rhizobacteria,10 and they are well-
known because of forming root nodules in legume crops.11 These associated microbes 
help plants overcome biotic or abiotic adversities in the environment, by providing host 
plants limited nutrients like phosphates and nitrates,12,13 secreting growth promoting 
factors.12,14 enhancing the tolerance to extreme conditions like drought, heat waves, high 
salinity or ion toxicity,14 as well as increasing disease resistance of plants.14,15  
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Beside rhizosphere associated microbes, the symbiotic microbes living in the plant 
tissues have drawn increasing attention, which are named as endophytes (endo means 
living inside and phyte means plants, in Latin).16 Endophytes are defined as 
microorganisms living in plant tissues without causing perceptible pathological 
symptoms,17–20 but there is no clear boundary between endophytes and plant pathogens. 
Many pathogenic species can also be isolated as endophytes from healthy plant 
tissues.16,21 On one hand, evidence showed the signaling pathways are essential to 
maintain the endophytic association, and signaling interference can switch endophytes 
from mutualism to pathogenism.21 On the other hand, the mutation or disruption of 
certain virulent genes can also change pathogenic fungi into endophytes.22,23 Therefore, 
distinguishing the trophic strategy between pathogenic and endophytic life is problematic. 
It is compelling that the endophytic systems are balanced by the interactions or 
communications between each individual, which determine the role of associated 
microbes. 
Endophytes are one of the most cryptic community and they have been remained 
unexploited for decades after the first discovery,12,18 because they are showing less 
manifest phenomena than other associated microbes mentioned above. Even in the 
middle of the 90s the term of “endophyte” was still controversial.16 Thus far, all plants 
are proven to harbor endophytes and “endophytism“ is a common phenomenon in the 
plant kingdom.24 
Most of the endophytes reported till now are fungi or bacteria (including actinomycete),18 
but different types of endophytes are possible to be unveiled in the future because the 
majority of endophytes are probably uncultivated yet (for example, endophytic virus).25 
Metagenomic research showed that the role of endophytes residing in plants remains 
largely unclear,3,26,27 even though there are nearly 10,000 publications on the topic of 
endophytes according to Web of Knowledge search to date. 
1.2 Why we study endophytes 
Comparing to phyllosphere epiphytes or rhizosphere microbes, endophytes are living in 
the tissue of plants, and have the closest relationship with host plants.2,17,18,21,28,29 In the 
endophytic lifestyle, the host defenses are suppressed as well as the growth and 
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virulence of endophytes, and the micro-ecological systems are regulated in complex and 
precise manners to allow the co-existence of each other.18,21 The mechanism to 
maintain the balance between endophytes, host and other associated microbes is poorly 
understood to date,18 which is a fascinating and challenging topic of exploiting 
endophytes in the fields of biotechnology.  
30 years ago in the United State, the fescue toxicosis of livestock caused by feeding tall 
fescue (Festuca arundinacea) drew the attention of scientists.30 Investigation showed 
the reason is the toxic peptide and clavinet ergot alkaloids produced by the endophytic 
fungus Neotyphodium coenophialum harbored in tall fescue.30 Moreover, the endophytic 
fungi infected grasses were reported to be toxic against insect and other mammalian 
predators as well.31 This milestone case inspired scientists that these endophytes 
harbored in plants are capable of defending hosts against invaders or predators to 
obtain the competitive advantages.18 In the later research, it is believed that endophytes 
are helpful to enhance their hosts tolerance towards diverse ambient stresses.32 To 
defend against biotic invaders, endophytes provide not only chemical warfare to inhibit 
pathogens but also communication interference strategies to attenuate virulence of 
pathogens (for example, quorum quenching).33 These ecological traits suggest that the 
investigation on endophytic chemical basis may lead to the development of novel clinical 
drugs, to tackle current major problems including bacterial resistance towards 
antibiotics.33 Because most endophytes have not been well-investigated yet, the 
ecologically functional natural products from endophytes were considered as a 
promising resource of new compounds.34 A review stated that the possibility to discover 
unknown bioactive compounds from endophytic fungi was 51%, whereas it is only 38% 
for soil fungi, according to the survey of published new natural products.35 With respect 
to their ecological relevance, natural product research on endophytes has resulted in 
extraordinary success in the past two decades, with a great number of antimicrobial or 
anticancer agents discovered,25,34,35 and the number is keeping increasing. However, 
most of the compounds were obtained from in vitro axenic monocultural fermentation,19 
which led to a debatable question that whether these bioactive compounds are also 
produced in natural niches of endophytes since most of them were proposed as 
biofunctional compounds for the fitness of host plants. Connecting these bioactive 
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compounds with the function of endophytes in their niches is still a challenging task with 
current technologies. 
 
Figure 1. Representative plant natural products with alternative endophytic sources 
In 1993, another historic discovery was published in Science that valuable anti-cancer 
agent paclitaxel (Taxol®) was detected to be produced by an endophytic fungus 
Taxomyces andreanae, which is harbored in the inner bark of pacific yew (Taxus 
brevifolia).36 Thereafter, many research were focusing on the endophytes which are 
capable of producing or partially producing bioactive compounds previously thought to 
be plant-originated.17–20,25 Some other outstanding examples have also refreshed the 
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perspective of us for endophytes and host plants, including podophyllotoxins,37,38 
camptothecins,39–44 huperzine A,45–50 hypericin and emodin,51,52 vinblastine and 
vincristine,53 maytansine,54 piperine,55 azadirachtin A and B,56 silybin A and B,57 
isosilybin A,57 ginkgolide B,58 phillyrin,59 sanguinarine,60 and gymnemagenin 61 (Figure 1 
and Table 1).  
Table 1. Representative plant natural products with alternative endophytic sources 
Natural products from 
plant material 
Plant sources Endophytic producers References 
Paclitaxel Taxus sps.  
Corylus avellena 
More than 200 fungi and bacteria 
belonging to more than 40 genera 
62,63 
Podophyllotoxins Podophyllum sps. 
Juniperus sps. 
Trametes hirsute 
Phialocephala fortinii 
Aspergillus fumigatus Fresenius 
37,38,64  
Camptothecins Camptotheca 
acuminate 
Nothapodytes 
sps. 
Trichoderma atroviride LY357 
Fusarium solani 
Fomitopsis sp. P. Karst 
Alternaria alternate (Fr.) Keissl 
Phomposis sp. 
Neurospora sp. 
Entrophospora infrequens 
39–44 
Huperzine A Family 
Huperziaceae 
Paecilomyces tenuis YS-13 
Colletotrichum gloeosporioides 
45–50 
Hypericin and emodin Hypericum sps. Chaetomium globosum 
ThielaVia subthermophila 
51,52 
Vinblastine and 
vincristine 
Catharanthus 
roseus 
Fusarium oxysporum 53 
Piperine Piper longum Periconia sp. 55 
Azadirachtin A and B Azadirachta 
indica  
Eupenicillium parvum 56 
Silybin A, silybin B, 
and isosilybin A 
Silybum 
marianum 
Aspergillus iizukae 57 
Ginkgolide B Ginkgo biloba Fusarium oxysporum 58 
Phillyrin Forsythia 
suspensa 
Colletotrichum gloeosporioides. (Penz.) 59 
Sanguinarine Macleaya cordata Fusarium proliferatum BLH51 60 
Maytansine Putterlickia sps. 
Maytenus sps. 
Bacterial community harbored in the 
host plant 
54 
Gymnemagenin Gymnema 
sylvestre 
Penicillium oxalicum 61 
 
Because the controlled microbial fermentation is much more efficient and easier to 
scale-up for the industry, people have been attempting to utilize endophytes as a 
sustainable source for precious pharmacy-relevant natural products from limited plant 
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material.17 Even though recent development enables the heterologous expression of 
biosynthetic pathway in other organisms, there are still many technological bottlenecks. 
As a representative example, the heterologous biosynthesis of final product paclitaxel is 
still impossible, because of the lack of understanding on several key steps.65 For 
instance, when the cP450’s (key enzymes for the final biosynthesis of paclitaxel) were 
expressed in heterologous systems, they presented no functionality because of incorrect 
folding, translation and insertion to the cell membrane.66,67 On the contrary, these 
endophytes are naturally occurred “heterologous host” with biosynthetic capacity of 
producing plant natural products (PNP), which can be readily obtained without artificially 
engineering of plant biosynthetic machinery to mimic PNP pathways in microbes.67,68 
However, to date all efforts to maintain the biosynthesis of target compounds in large-
scale fermentation do not succeed.19 It appears that the triggers or other essential 
factors from the natural niches were lost in the fermentation conditions.39,67,69 For 
instance, there are approximately 200 fungi strains belonging to 40 fungal genera 
capable of producing paclitaxel, but no scale-up fermentation for the industry has been 
reported yet.20,67 It is compelling that some biosynthetic genes of endophytes are only 
expressed in endophytic status, but barely expressed in mycelia status in artificial 
conditions, which was well exemplified by lolitrems producing fungus Neotyphodium 
lolii.70 Moreover, given that some unknown compounds might only be produced in 
natural niches, they could plausibly be missed in the process of conventional 
approaches. Therefore, new strategies should be developed to unravel these cryptic 
biofunctional compounds produced by endophytes. 
The promising future of the research on endophytes is a consensus of opinion among 
scientists in biotechnology.20 However, regardless of searching new compounds from 
endophytes or fermenting valuable agents discovered from plants, we have to answer 
many open questions such as: how do the endophytes produce bioactive compounds in 
plant tissues and avoid disturbing the balance of endophytic systems? How do the 
interactions happen between endophytes, host plants, and pathogens or predators? 
What is the chemical basis of communication in endophytic systems? How do the 
endophytes maintain the production of bioactive compounds in natural niches?  
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Indeed, chemists and biologists have already made significant progress in the research 
of endophytes. But there is still a long way to go to fully exploit the potential of 
endophytes. The realm of endophytes is like a Jigsaw puzzle just at the beginning. To 
put more small tessellating pieces to the giant picture of endophytes, herein, my work is 
committed to investigating the secondary metabolites from endophytic fungi and bacteria 
as well as the crosstalk basis and ecologically relevant bioactivities of them. 
1.3 Natural products, important basis of interactions of endophytic system 
In organic chemistry, natural products are mostly restricted to the secondary metabolites 
produced by organisms, which are not essential for the survival of producers.71 
Organisms, like microbes, plants, and lower animals, produce bioactive compounds to 
gain advantages in the process of evolution, although the biosynthesis pathways are 
energy consuming.71 Even though the development of synthetic chemistry such as 
combinatorial chemistry can assess enormous structures with unparalleled efficiency, 
natural products are still considered as an indispensable resource of bioactivity-related 
structures, because they have been naturally selected as biofunctional agents in 
competitive environments for billions of years.72 Scientists are mostly interested in their 
potential to be human’s arsenal to fight against challenging diseases including infections 
and cancer. In 2015, Nobel Prize in Physiology or Medicine was awarded jointly to 
Youyou Tu for the discovery of anti-malaria agent artemisinin,73 and William Cecil 
Campbell and Ōmura Satoshi for the discovery of anti-parasite agents ivermectin74 and 
avermectin,75 and their great contribution to human health. In recent few years, the 
number of natural products or natural product scaffold based compounds is expanding in 
the approved drugs.76 Particularly, the discovery of bioactive compounds from 
endophytes will not only enrich the lead compounds in the compound library but also 
provide us opportunities to understand the ecological functions of endophytes. Thus, all 
the isolated pure compounds from endophytes herein were evaluated by antibacterial 
assay, as the contribution to the continuous screening for antibacterial agents.77–79  
Because of the increasing pharmaceutical demand, the higher bioactivities of natural 
products demonstrate in the in vitro or in vivo screening models, the more attention will 
be paid on them.72 However, these “less interesting” inactive natural products may be 
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essential for organisms to adapt to the environment. For example, most pheromones 
produced by microbes are neither lethal nor toxic to other competitors, but still function 
for microbes to regulate their social behaviors and obtain competitive advantages.80 By 
secreting and sensing these pheromone molecules, microbes are able to communicate 
with other individuals as well as other inter-kingdom species like plants.80 Furthermore, 
even though many microbial antibiotics are generally considered as weapons, they are 
also signal molecules influencing the colonization, virulence, stress response, motility, 
and/or biofilm formation of microbes.81 Therefore, for investigating endophytic systems 
with complex relationships between microbes and plants, all detectable compounds 
including inactive compounds in bio-assay could be important.  
Herein, the secondary metabolites from endophytes which can be characterized for 
further investigation are all interesting for my projects. Moreover, MALDI-imaging-HRMS 
experiments were performed on the bio-samples (colonies of endophytes) to reveal the 
bio-functions of these metabolites. 
1.4 Host plant screening 
In this research, the main target is seeking the endophytes capable of producing 
physiologically active compounds, or communicating with other endophytes via signal 
molecules. I focused on the endophytes harbored in traditional Chinese medicinal (TCM) 
plants, which has more than 2500 years history of therapeutic application.82 Based on 
the accumulated knowledge of TCM, the possibility of discovering bioactive compounds 
from plants as well as endophytes is plausibly higher than random screening.83 Two 
candidate TCM plants, namely Narcissus tazetta (for the treatment of parotitis and skin 
infection), and Buxus sinica (for the treatment of furuncle), were selected for first 
screening because of their recorded medical effects relating to antibacterial activities. 
After the LC-MS profiling of secondary metabolites from host plants as well as isolated 
endophytes, endophytes from N. tazetta and B. sinica (Figure 2) were chosen for further 
investigation. 
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Figure 2. N. tazetta (left) collected from Fujian and B. sinica (right) collected from 
Shanghai 
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1. Overview of host plant 
1.1 Narcissus tazetta 
N. tazetta, a species in family Amaryllidaceae, is not only well-known as an ornamental 
plant in the south of China, but also a traditional medicine for the treatment of mumps, 
mastitis, carbuncles, and insect bites.84 The in vitro cytotoxicity assay against HepG-2 
and HCT116 cell lines revealed that the extracts from the bulbs of N. tazetta have even 
stronger activity than doxorubicin.85 The previous phytochemical research showed family 
Amaryllidaceae is a rich resource of alkaloids, which are related to the traditional 
medical uses.85 From species N. tazetta, bioactive compounds such as flavans,86 
polysaccharide,87 alkaloids,88 phenylethanoid and phenylpropanoid glycosides84 were 
also identified.  
1.2 Buxus sinica 
B. sinica, a species in family Buxaceae, is widely used as evergreen boxwood in China, 
because of its tolerance against pruning and shearing. This interesting property drew our 
attention to investigating the endophytes harbored in the leaves and stems, which may 
provide benefits for host plant against biotic or abiotic stress18 such as pathogens or 
harmful substance invading the wounds.89  
As a traditional medicine, B. sinica is applied for the treatment of syphilis, malaria, 
dermatitis, rheumatism, and rabies.90 More than 160 compounds were reported from 
genus Buxus, such as alkaloids, triterpenoids, steroids, flavonoids, coumarin, and 
lignans, with a broad range of bioactivities like cytotoxicity, anticholinesterase, antifungal 
activity, antibacterial, antileishmanial, phytotoxic, immunosuppressive and anticancer 
activities.91  
2. Overview of endophytes investigated herein  
2.1 Fungal species Fusarium solani  
F. solani, belonging to family Nectriaceae, is a widely distributed pathogenic fungus 
causing crop loss worldwide.92 F. solani is also reported as an opportunistic pathogen 
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for human, causing high mortality rate infections in immunocompromised patients.93 
However, it was also isolated as endophytes from healthy plant tissues. The F. solani 
strain isolated from the root tissue of tomato is beneficial for the host to suppress foliar 
and soil pathogens.94 Furthermore, in a former research at INFU, it was demonstrated 
that the endophytic strain of F. solani collaborates with host plant Camptotheca 
acuminata to biosynthesize anticancer agent camptothecin.41,95 Another research 
showed that one strain of F. solani as well as two other Fusarium species isolated from 
pigeon pea are capable of producing antioxidant cajanistilbene acid.96 These reports 
suggested that the ecological role of species F. solani might be variable in different 
natural niches. 
From the genus Fusarium, a great number of bioactive compounds have been identified, 
most of which are polyketides (PK) and nonribosomal peptides (NRP) with high 
structural diversity.97 Gene mining for polyketide synthase (PKS) and nonribosomal 
peptides synthetase (NRPS) revealed many unknown PKS and NRPS genes in the 
genus Fusarium, which suggests this genus is a potential resource for new natural 
products.97 
2.2 Bacterial species Achromobacter xylosoxidans 
A. xylosoxidans (family Alcaligenaceae) was widely distributed in the aquatic 
environment including intravenous fluids, well water and water in humidifier.98–100 
However, this species was firstly discovered and named from the patients with chronic 
purulent otitis media and described as aerobic, non-fermentative, gram-negative rod.101 
The strains of A. xylosoxidans showed to a wide range of resistance towards 
antimicrobial agents and five of the isolates possibly played pathogenic roles in the 
former research.102 The full genome sequence of an A. xylosoxidans strain from a cystic 
fibrosis patient was published in 2013.103 
Interestingly, A. xylosoxidans was also isolated as functional endophytic bacterium from 
the roots of Phragmites australis and Ipomoea aquatic, which can improve the aromatic 
pollutants removal rate when it is harbored in host plant Arabidopsis thaliana.104,105  
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2.3 Fungal genus Colletotrichum 
The genus Colletotrichum belongs to family Glomerellaceae and it includes major 
important plant pathogens causing devastating diseases of many woody and 
herbaceous plants, such as anthraconose diseases.106–110 After a short symptomless 
period in the early stage of Colletotrichum infection, the fungi change to a necrotrophic 
phase and result in significant death of plant tissues and the emergence of pathogenic 
lesions via host-induced virulence effectors.110 However, some species were also 
reported as endophytes causing no symptoms harbored in the leaves,111–115 fruits,59,116 
branches117 or stems55,118 of plants. The investigation on the conversion between 
pathogenic strain and endophytic strain of Colletotrichum magna showed that single 
mutation or disruption of a pathogenicity gene would transform it from a pathogen to an 
endophytic mutualist.22,23 
Colletotrichum species are able to produce alkaloids, polyketides, and cyclic peptides 
with high structural diversity and broad range bioactivities.109,114,117–124 Moreover, the 
strain Colletotrichum gloeosporioides TA67 isolated from anglojap yew (Taxus x media) 
was reported as a paclitaxel producer.125 And another strain of C. gloeosporioides 
isolated from Piper nigrum is capable of producing piperine, which is a characteristic 
natural product from the host plant.55 Furthermore, by screening the endophytic fungi in 
Huperzia serrata, researchers discovered that the isolated strain of C. gloeosporioides is 
a producer of Alzheimer's disease medicine huperzine A, which was supposed to be 
produced by host plants.45–48  
Some bioactive compounds from this genus were documented as phytotoxic metabolites 
playing a significant role in pathogenesis.109 Other antimicrobial, antioxidant, 
immunosuppressive or cytotoxic compounds might be beneficial agents for the fitness of 
host plants against biotic or abiotic stresses.114,115,118,119,122–124,126 
2.4 Fungal species Phyllosticta capitalensis (teleomorph Guignardia mangiferae) 
The genus Phyllosticta (family Botryosphaeriaceae) includes many species of plant 
pathogens and endophytes.127 P. capitalensis is generally considered as endophytic 
fungus,127 although it was reported to cause leaf blight of Elaeocarpus glabripetalus128 
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and spots on leaves and fruits of mango and guava.129,130 Comparing to the closely 
related pathogenic species G. citricarpa, P. capitalensis produces a significantly smaller 
amount of amylases, endoglucanases and pectinases, which might be the keys for 
virulent species to cause citrus black spots on plants.127 For the secondary metabolites, 
P. capitalensis was able to produce meroterpenes with toll-like receptor 3 regulating 
activity.131–133  
2.5 Bacterial genus Herbaspirillum 
Genus Herbaspirillum (family Oxalobacteraceae), a group of gram-negative diazotrophic 
bacteria, belongs to betaproteobacteria which includes a great number of plant-
associated bacteria.134 It used to be considered as a new Azospirillum species, because 
of its cell appearance, growth behavior and habitat in grass roots.134 Herbaspirillum 
species aggressively colonize the whole plant not only in the cortex and vascular tissues 
but also intercellular spaces as endophytes,134 and some species were even detected in 
intact root cells.135 Most species in this genus are harmless endophytes, while few 
species cause diseases including red stripe on some sorghums and mottled stripe 
disease on sugarcane.136 The significance of this genus is the nitrogen fixing capacity, 
which provides substantial nitrogen source and promotes the growth of host plants 
(especially for the economical crops like sorghum, sugar cane, rice, and maize).136 
Although Herbaspirillum species are not known as human pathogens, they were also 
isolated from 28 patients with cystic fibrosis as reported previously.134   
3. Overview of the microbial secondary metabolites 
investigated herein 
3.1 Biosynthetic pathways of nonribosomal peptide synthetase (NRPS) and polyketide 
synthase (PKS) 
NRPSs and PKSs are two essential secondary metabolic pathways of organisms 
especially microbes, the products of which represent a huge family of bio-functional 
natural products including siderophores, toxins, antibiotics, pigments, 
immunosuppressants, and cytostatics.137–139 The enzyme complexes of these two 
pathways synthesize secondary metabolites by conserved thiotemplate mechanism, 
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providing unparalleled structural diversity for drug development. Many clinically applied 
drugs including vancomycin, erythromycin, cyclosporine, rapamycin, bleomycin, and 
epothilone are derived from NRPS or PKS pathways.137–139 The microbial products 
investigated in this thesis are all biosynthesized by these two pathways or their hybrid 
pathways. 
 
Figure 3. The chain elongation of NRPS biosynthesis pathway 
Unlike ribosomal peptides synthesis, nonribosomal peptides (NRPs) are a group of 
peptides synthesized by multimodular nonribosomal peptide synthetases enzyme 
clusters (NRPS) independent of mRNA and tRNA.140 Remarkably, the building blocks of 
NRPs are not confined to 20 proteinogenic amino acids. Reported NRPs present more 
than 500 different monomers including nonproteinogenic amino acids and fatty acids.140 
The selectivity of these enzymes for specific amino acid is still ambiguous.141 Moreover, 
D-amino acids are also present in NRPs because of the epimerization-domain (E) in 
NRPS modules.142 This property enables the high structural diversity of NRPS products 
with broad range of bioactivities.140 NRPSs consist of an array of enzyme modular 
sections (Figure 3), in which each section is responsible for incorporating each monomer 
into the growing NRP chains.140 Beside E domains, three domains, namely adenylation 
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domain (A), thiolation or peptidyl carrier protein domains (PCP) and condensation 
domain (C), are essential for peptide elongation and ubiquitous in NRPSs.140 Typically, 
at the end of the assembly lines of NRPSs as well as PKSs, thioesterase domains (TE) 
is responsible for the macrocyclization and final product release.143 
PKSs are multienzyme systems with large molecular weight from Mr. 100 to 10,000 KDa, 
which synthesize extraordinarily complex polyketides stepwise from simple building 
blocks like acetyl-CoA, propionyl-CoA, butyryl-CoA or their other derivatives.144 The 
reaction of linking the chain-building blocks is decarboxylative condensation, which is an 
analogue of the chain elongation step of primary metabolic fatty acid biosynthesis.144 
The genetic, protein-structural and mechanistic analyses reveal astonishing similarity 
between PKSs and fatty acid synthases.144–149 However, the elongation of PKSs lacks 
one or multiple steps of consequent keto-reduction, dehydration, and enoyl reduction in 
the chain extension of fatty acid biosynthesis, resulting in remaining functional groups 
(hydroxyl, double bond, ketone groups, etc) on the aliphatic chain which is feasible for 
numerous reactions such as cyclization, oxidation, acylation or other modifications.144–149 
This remarkable character leads to high level of structural diversity and versatility of final 
PKS products.146  
To date, PKSs are known to have majorly three types (type I−III).146 Type I PKSs are 
large multidomain enzyme modules carrying all the active sites for polyketide 
biosynthesis, and each module has a set of distinct, catalyzing one cycle of polyketide 
chain elongation non-iteratively (the function domain of each module are different) 
(Figure 4A).144–149 This type of PKS is similar to vertebrate fatty acid synthases, and the 
typical compounds are erythromycins.148 In contrast, type II PKSs comprise several 
iterative modules (typically monofunctional) (Figure 4B), which is similar to the bacterial 
fatty acid synthases,144–149 as exemplified by biosynthesis of doxorubicin150 and 
actinorhodin.151 Unlike type I and II PKSs, type III PKSs have no ACP and catalyze 
elongation reaction directly on the acyl-CoA substrates (Figure 4C),144–149 as exemplified 
by biosynthesis of flavolin.152 
Because of the similarity of these two pathways, notably, PKSs and NRPSs are able to 
fuse hybrid pathways utilizing both PKS and NRPS building blocks. For example, 
Chapter 2: Outline of literature 
 
23 
 
compounds bleomycin,153 yersiniabactin,154 epothilone,155 and rapamycin156 are 
polyketide-amino acid hybrid molecules synthesized by hybrid PKS and NRPS pathways. 
This flexible combination expands the capacity of NRPS/PKS to produce compounds 
with surprising structures.141 Insights into the molecular mechanism of biosynthesis 
pathway offer us the opportunity to explain the ecological role of natural products as well 
as their microbial producers.141 Furthermore, the engineering of NRPS/PKS might 
enable us to synthesize new chemicals which are difficult to obtain via conventional 
synthetic methods.141 
 
Figure 4. The chain elongation of type I−III PKS biosynthesis pathways  
3.2 Cyclic peptides 
Cyclic peptides are polypeptide chains synthesized via NRPS pathway without free N- 
and C- terminal because of the cyclization from head to tail.157 The linking bonds of ring 
system are not limited to peptide bond, and other stable bonds such as lactone, ether, 
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disulfide, thioether are also very common in the main scaffold.157 On one hand, this 
property leads to much higher tolerance towards degradation in organisms or in the 
environment than the linear peptides.157 On the other hand, the ring systems have rigid 
conformation, which may result in reinforced binding of molecules towards target 
receptors.157 Many cyclic peptides have strong bio-activities and ecological functions, 
which can be exemplified by natural toxins amanitins158 and microcystin.159 Several of 
them are applied clinically as well. For example, antibiotics such as vancomycin,160 
gramicidin,161 daptomycin,162 and tyrocidine163 are typical cyclic peptides.  
3.3 Azaphilones 
Azaphilones have a common isochromene core structure (Figure 5), belonging to the 
group of polyketides biosynthesized by PKS pathways.164 Some of them are substituted 
by halogen on the olefinic carbons (most commonly chlorine substitution at position 5). 
They are mostly produced by numerous species of basidiomyceteous and 
ascomyceteous fungi, including genera Chaetomium, Aspergillus, Penicillium, 
Pestalotiopsis, Phomopsis, Talaromyces, Emericella, Monascus, Epicoccum, and 
Hypoxylon.164 Some azaphilones are characteristic metabolites of certain species, which 
can be utilized as important chemotaxonomical markers.165–167  
Azaphilones are not only pigments produced by fungi but also molecules with a 
significantly wide range of biological effects, including antimicrobial, cytotoxic, antiviral, 
anti-inflammatory and anticancer activities.164 Several azaphilones are reported to be 
inhibitors of gp120-CD4 binding (anti-HIV related assay),168 Grb2-SH2 interaction 
(anticancer related assay),169 MDM2-p53 interaction (anticancer related assay),170 and 
heat shock protein 90 (Hsp90, anticancer related assay).171  
 
Figure 5. Basic azaphilone scaffold 
Chapter 2: Outline of literature 
 
25 
 
 
Figure 6. Reported lactam-fused 4-pyrones 
3.4 Lactam-fused 4-pyrones 
Lactam-fused 4-pyrones are biosynthesized via hybrid PKS/NRPS pathway, with 
pyrano[2,3-c]pyrrole basic scaffold (Figure 6).172 In the former investigation, these 
compounds were isolated from Cordyceps sp.,173 Curvularia pallescens,174 and 
Aspergillus niger.172,175–179 The compounds pyranonigrin E and F have confusing 
common names of nomenclature, with one name assigned to two different compounds 
respectively. Pyranonigrin A and F178 showed potent antimicrobial activities against a 
broad spectrum of human, aquatic, and plant pathogens.178  
  
Chapter 2: Outline of literature 
 
26 
 
4. Technical development of structural elucidation for 
unknown organic molecules 
4.1 MSn technology for cyclic peptides sequencing  
Tandem mass spectrometry (MS/MS) or multiple stage mass spectrometry (MSn) consist 
of two or more stages of MS, associated with the dissociation of certain mass weights 
between each stage. With low energy dissociation method, peptides most frequently 
cleavage at peptide bonding to generate b or y ions (Figure 7).180 The b ions can further 
lose a CO group to generate a ions (Figure 7),180 which is a major difference between b 
or y ions. Because most building blocks of peptides, namely amino acids, have different 
molecular weights (except some isomers like leucine and isoleucine), MS/MS becomes 
an efficient tool for peptides and even protein analysis and sequencing, due to its 
efficiency, robustness, sensitivity, and versatility.181 For the linear peptides, the well-
defined N- and C- terminal can be the unambiguous anchors to assign the sequence of 
amino acids in a certain order in MS/MS,182–184 and the automatic analysis by software is 
also well established.185,186 
  
Figure 7. Representive a, b, c, x, y, and z ion pattern of linear peptides 
For cyclic peptides, however, the sequencing is much more challenging, because of the 
absence of terminal amino acid.187 Unlike linear peptides, the mass loss of amino acids 
in cyclic peptides results from cleavage of at least two bonds in the ring system, which 
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can randomly occur at several backbone positions.187 Without the reference of terminal 
amino acid, the fragments of cyclic peptides in MS/MS have many overlapping units and 
cannot be organized in an orderly fashion.187  
After the development of MSn technologies, multistep fragmentation enables the 
analysis of amino acid sequence of each fragment obtained from the MS2 of cyclic 
peptides, associated with low energy dissociation method (collisionally activated 
dissociation, CAD; also known as collision-induced dissociation, CID).187–191  
4.2 Density functional theory (DFT) gauge-including atomic orbitals (GIAO) 13C NMR 
shielding tensor calculation 
Although the developments such as nuclear magnetic resonance (NMR) and MS 
technologies have been unprecedentedly promoting the structure elucidation of organic 
compounds, in some cases these technologies cannot always work out with satisfactory 
results.192,193 Consequently, structures of some reported natural products including the 
molecules with interesting bioactivities are incorrectly assigned in the literature,192,193 
and the work of total synthesis or further biological investigation will take the risk of 
wasting enormous time, money and efforts.194  
The shielding tensor of NMR spectroscopy is one of the most important atomic 
properties. As the successful progress made by DFT, the accurate GIAO shielding 
tensor DFT calculation was also proposed and practically applied by Schreckenbach et 
al.195 and Cheeseman et al.196 Barone et al. had done pioneering work that they 
employed GIAO 13C NMR calculations to revise the misassigned structures and 
assigned the relative configurations of several natural products, which showed us the 
GIAO 13C NMR calculation can be a powerful tool to solve the problematic structural 
assignment and secure the structure elucidation by NMR assignment.197,198 Notably, for 
the famous complex compound maitotoxin, O. Frederick et al. utilized GIAO 13C NMR 
calculation to verify the controversial sub-structure.199 In many cases, the GIAO 13C 
NMR calculation showed astonishing accuracy and reliability and was successfully 
applied in the structure elucidation.200–206 Smith et al. adopted a multiple standard 
method (MTSD) using benzene (for sp2 and sp carbon) and methanol (for sp3 carbon) as 
references, which showed improved accuracy in the benchmark of different organic 
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compounds.207 With the hybrid functional mPW1PW91 and small basis set 6-31G(d), the 
averaged MAD and RMS for the test sets is only 2.1 ppm and 4.9 ppm respectively.207 
Based on the efficiency and accuracy of GIAO 13C NMR calculation, Sarotti et al. 
combined geometry optimization with computationally inexpensive approaches like MM+, 
AM1 or HF/3-21G and NMR shielding constants calculation on mPW1PW91/6-31G(d) 
level of theory, into a new strategy for simple and rapid identification of proposed 
structures.194 This strategy of GIAO 13C NMR calculation is helpful for preventing the 
publication of wrong structures and the consequences of these mistakes.194 
5. Strategies for microbial chemical crosstalk investigation 
5.1 What is microbial chemical crosstalk  
In natural niches, microbes face myriad environmental factors and they adopt internal 
species or species to species communication as an essential strategy to survive. Since 
the end of 1970s the investigation on mechanisms of controlling bacterial 
bioluminescence opened a gate to reveal that bacteria are not unconscious organisms 
but social individuals, which are capable of achieving group behaviors and 
accomplishing complex tasks via cell to cell communication.208–215 Hereafter, since the 
beginning of 1980s, N-Acyl homoserine lactones (AHL) and autoinducers 2 (AI-2) were 
discovered as corresponding signaling molecules, of which the concentration is 
correlated to the population density and utilized by bacteria to control social behavior by 
altering gene expression.209 Therefore, the term quorum sensing was proposed and 
stupendous progress was accomplished upon the mechanism of the cascade signaling 
pathways.208–215  
However, more and more phenomena exhibit so-called quorum sensing molecules do 
not only function for “quorum sensing (QS)”, but also for different functions including 
regulating virulence factor production, formation of inner-species or inter-species biofilm, 
dormancy, and competence.208–215 These so-called QS molecules are also able to 
influence the functions of other eukaryotic species such as fungi, plants or even 
mammals, which is known as inter-kingdom communication.214,216 Moreover, chemical 
communication behaviors were observed in the investigations on fungi as well, which 
shared homologous characters as bacterial quorum sensing molecules.12,212,217 The 
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chemical language spoken in microbes implicates the sophisticated social networks 
connecting them, their neighbors, or their host, and the extensive influence is far beyond 
the initial definition of “quorum sensing”.214,218 Therefore, chemical crosstalk, which is a 
vivid description of the dialogue-like chemical communication or interaction between 
microbes, is suitable not only for bacteria but also other microbes.  
5.2 Visualization of chemical crosstalk 
As the general procedure of microbial natural product investigation, strains are firstly 
purified and then subjected to large-scale fermentation to obtain sufficient quantity of 
pure compounds for further investigation. However, microorganisms are living in 
complex niches consisting of many different other individuals, which results in the 
difficulties for investigating the ecological roles of bioactive compounds by conventional 
strategies. For uncultivable microbes, which are the remaining untapped sources of new 
biofunctional compounds, the research on secondary metabolites requires complex in 
situ approaches.219,220  
 
Figure 8. The flow chart of MALDI IMS measurement 
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Thus, scientists have been developing experimental techniques to resolve these 
challenges, resulting in the invention of many novel technologies including the imaging 
mass spectrometry (IMS) for the visualization of chemical maps in complex biological 
samples.221–224 As one of the extraordinary examples, MALDI ion source was initially 
developed to analyze high polar, ionic, and high molecular mass compounds, and it 
could also be applied to samples without complex pre-treatment for MS 
measurement.225–227 The specific matrix consists of small organic compounds with 
strong resonance absorption to laser with certain wavelength.225 Matrix can transfer 
controllable energy to the matrix-analyte mixture in a manner of uniform and soft 
desorption, as well as promote the ionization of analytes by chemical reactions or 
charge transfer.225 It showed outstanding advantages on intact cell metabolites profiling, 
which allow us to measure a small location on the surface of samples without disturbing 
other parts, and organize the MS information of each location as pixel to obtain chemical 
maps on the samples (Figure 8).221–224 This method comprises five main steps, namely 
sample preparation, matrix application, dehydration of samples, data acquisition, and 
data processing.228 Although the MALDI IMS analysis is rapid and simple because it only 
needs mixing the matrix with the analytes, the sample preparation is still challenging.228 
Those samples, which are difficult to yield flat and stable surfaces, are not suitable for 
MALDI IMS measurement.228  
Some similar methods like desorption/ionization on silicon mass spectrometry (DIOS MS) 
are able to analyze small natural products without the interference of matrix signals.228 In 
addition, there are also some ion source of IMS requiring no sample pre-treatment, such 
as desorption electrospray ionization (DESI) and nanospray DESI, which allows us to 
profile the metabolites directly under ambient conditions.229 Notably, the technology of 
liquid micro-junction surface sampling probe (LMJ-SSP), using micro tube extract 
system with solvent flow, are also capable of producing IMS of living organisms.230 
The application of IMS on microbial crosstalk successfully brought the interaction of the 
microbial world to light in the recent decade, and provided us insights to the microbial 
interaction.228 For example, Bacillus. subtilis is mostly investigated bacterium by IMS, 
which secretes several secondary metabolites to compete or communicate with other 
species, including subtilin, subtilonsin, surfactins, plipastatins and bacillaene.228 IMS was 
Chapter 2: Outline of literature 
 
31 
 
used to search for the cannibalistic toxins produced by B. subtilis, track the metabolites 
exchanged between it and Streptomyces sp. Mg1, as well as observe the chemicals 
produced in the microbial assemblage comprising B. subtilis SIO-1 and 
Promicromonosporaceae strain SIO-11.228 Moreover, IMS is also an important tool for 
the investigation of endophytic microbes. Especially for the investigation of endophytes 
in their natural niches, IMS technology presented unmatched ascendancy that was 
exemplified by the visualization of maytansine production of endophytic microbial 
community in Putterlickia roots.54 
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1 Aim of research 
The aim of this research was to search bioactive or biofunctional secondary metabolites 
from endophytic fungi and bacteria harbored in traditional Chinese medicinal plants. 
After pre-screening the endophytes isolated from several collected plant materials, the 
subjects were determined to be the endophytic fungi and bacteria isolated from plant N. 
tazetta and B. sinica. 
The general workflow of this research is showed as follow: 
Collecting plant samples of N. tazetta and B. sinica from different location of China and 
measuring the LC-MS chromatograms of the extracts from plant samples as metabolites 
fingerprints data. 
Isolating, purifying and identifying endophytic fungi and bacteria from plant tissues. 
Analyzing the metabolites produced by obtained endophytes in many different 
fermentation conditions by LC-MSn. Targeting these secondary metabolites having 
sufficient amount for further research, as well as having novel fragmentation pattern in 
MSn spectra.  
Accumulating enough amount of compounds for structural identification and bioassay by 
large-scale fermentation.  
Proposing possible bio-functions of these compounds based on the identified structures. 
Designing proper experiments to check whether these compounds have bioactivities or 
biofunctions by IMS and bio-assay. 
1.1 Hexacyclopeptides from endophytic F. solani N06 and their plausible ecological 
function 
Investigating on the hexacyclopeptides produced by F. solani N06 in stationary condition 
including structure elucidation via MSn, and stable isotope labeling to verify the original 
producer. 
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Investigating the plausible ecological functions of these hexacyclopeptides as well as the 
interaction between isolated endophytes from the same plant tissue including endophytic 
F. solani N06 and bacterium A. xylosoxidans N12B.  
1.2 Antibacterial azaphilones from endophytic fungus Colletotrichum sp. BS4 
Optimizing the fermentation condition for the strain Colletotrichum sp. BS4 to obtain 
enough amount of azaphilone type compounds. Purifying targeted new azaphilones 
from the crude extracts of fermented biomass by extensive chromatographic techniques. 
Elucidating the structure of these compounds via spectroscopic technologies including 
1D, 2D NMR and MS, X-ray diffraction as well as the quantum chemistry calculation of 
ECD and NMR properties. 
Evaluating the antibacterial activities as well as the cytotoxicity of these compounds to 
examine the potential for further antibiotic development. Visualization of these 
compounds in the fungal colony to propose the possible bio-functions. 
1.3 Lactam-fused 4-pyrones produced by endophytic fungus P. capitalensis BS5 and its 
endosymbiont. 
Optimizing the fermentation condition for the endosymbiotic system to yield sufficient 
amount of lactam-fused 4-pyrones for further investigation. Elucidating the structures of 
these new compounds via diverse spectroscopic method and ab initio DFT NMR 
calculations.  
Based on the structure, proposing the possible biosynthesis pathway and then analyzing 
the corresponding biosynthetic genes to verify the original producer(s) in this 
endosymbiotic system. 
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1. General experimental procedures and instruments 
A. KRÜSS Optronic polarimeter P8000-T was used for optical rotation measurement, 
and ECD were recorded by a Jasco J-715 spectrometer.231 IR spectrum measurements 
were performed on a Bruker IR spectrometer TENSOR27.231 NMR spectra were 
measured by a Bruker DRX-500 spectrometer with frequency 500 (1H) and 125 (13C) 
MHz using TMS as reference standard.231 HRMS and HRMSn experiments were 
performed using a LTQ-Orbitrap spectrometer (Thermo Fisher, USA) equipped with an 
HESI-II ion source.231 The LC system for LC-MS is Agilent 1200 HPLC system 
consisting of pump, PDA detector, column oven (30 C), and autosampler (injection 
volume 5 µL for every sample).231 The LC column was NUCLEODUR® C18 Gravity, 1.8 
µm, 2 mm × 30 mm. Ion source parameters: heater temperature: 400 °C; sheath gas 
flow rate: 60 a.u., gas flow rate 12 a.u.; sweep gas flow rate 0 a.u.; spray voltage 4.60 
kV, capillary temperature: 350 °C; capillary voltage 25 V, tube lens voltage: 65 V.231 Full 
scan MS parameters: mass range: 190−1000, resolution: 60,000 (m/z 400), polarity 
mode: positive, lock masses m/z 214.0896 and 231.1161 ([M+H]+ and [M+NH4]
+ adducts 
of N-butylbenzenesulfonamide, C10H15NO2S, respectively).
69 Semi-preparative HPLC 
consists of a Gynkotek pump, a Dionex DG-1210 degasser, a Dionex UVD 340S 
detector, and a Dionex Gina 50 autosampler with Venusil XBP (2) C18 column (10  250 
mm).231 Column chromatography was using silica gel 60 (70-230 mesh; AppliChem, 
GmbH, Darmstadt, Germany) as stationary phase.231 Solid phase extraction (SPE) 
Columns BAKERBOND speTM C18 polar plus were purchased from J.T.Baker, Avantor 
Performance Materials B. V., Deventer Netherlands.130 Thin-layer chromatography (TLC) 
was performed with pre-coated silica gel 60 plates (0.25 mm; Merck, Darmstadt, 
Germany). Spots were visualized by UV light at 254 nm and 365 nm, and by spraying 
with 10 % H2SO4 (v/v) EtOH solution followed by heating at 120 °C.
231  
α-Cyano-4-hydroxycinnamic acid (HCCA; >99.0 %) was purchased from Sigma-Aldrich 
life Science, USA. Ethyl acetate (EtOAc), MeOH, CH2Cl2 and acetonitrile were HPLC 
grade from J. T. Baker, Avantor Performance Materials B. V., Deventer Netherlands.69 
Mobile phase water was double distilled deionized water.69 Analytical-grade amino acids 
were provided by AppliChem, Darmstadt, Germany. Triethylamine (>99.5%), chemical-
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grade acetaldehyde (99%), trifluoroacetic acid (TFA; 99 %), N-Boc-4-oxo-L-proline 
methyl ester, NaBD4 and Dowex
TM 50WX8-100 resin were purchased from Sigma-
Aldrich, Steinheim, Germany.69  
All the commercial media for microbes were purchased from Sigma-Aldrich. Constitution 
of media: Potato dextrose broth (PDB), potato extracts 4 g, dextrose 20 g, in 1 L; potato 
dextrose agar (PDA), potato extracts 4 g, dextrose 20 g, agar 15 g, in 1 L; Sabouraud 
dextrose agar (SDA), mycological peptone 10 g, dextrose 40 g, agar 15 g, in 1 L; 
nutrient agar (NA), meat extract 1 g, peptone 5 g, sodium chloride 5 g, yeast extract 2 g, 
agar 15 g, in 1 L; nutrient broth (NB), meat extract 1 g, peptone 5 g, sodium chloride 5 g, 
yeast extract 2 g, in 1 L; solid rice medium consisted of 1 : 1 (w/v) rice and water, which 
had been sterilized at 120 °C in autoclave; rice agar (RA), 20 g rice flour, 15 g agar, in 1 
L. Petri-dishes were purchased from TPP, Trasadingen, Switzerland. And the 6 mm 
sterile diffuse assay paper disks were provided by Schleicher & Schuell GmbH, Dassel, 
Germany.69  
2. Isolation and culture of endophytes 
2.1 Collection and identification of host plants 
Each tissue was recorded by photography and then carefully cut from host plants. The 
wounds of tissues were covered by Parafilm® to prevent water loss. Then they were 
transported in sealed plastic bags and preserved at 4 °C within 48 h of collection before 
processing. N. tazetta was collected from Zhangzhou, Fujian Province, People’s 
Republic of China, in November 2012, which was identified by Shanghai Botanical 
Garden.69 B. sinica was collected from Guangzhou, Guangdong Province, People’s 
Republic of China, in November 2013, which was identified by South China Botanical 
Garden.130,231  
2.2 LC-MS analysis of plant extracts 
A part of collected tissues (about 2−10 g) was dried and crushed in liquid N2, and then 
extracted by CH2Cl2 : MeOH (1 : 1, v/v) (for low polar compounds) and MeOH (for high 
polar compounds) successively. The extraction solution was concentrated under 
vacuum in 40 °C water bath. All the crude extracts were weighted and prepared into 1 
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mg/mL MeOH solution for LC-MS/MSn measurement. The LC condition was used 
acetonitrile: water system with 0.1 % formic acid. The general gradient was set to be: 0-
2 min, 0% acetonitrile; 2 min-30 min, 0%-100% acetonitrile; 30-34 min, 100% acetonitrile; 
34-35 min, 100-0% acetonitrile. The column was NUCLEODUR® C18 gravity (1.8 µm 2 
mm×30 mm) and flow rate was 0.4 mL/min, and the column oven temperature was 
30 °C.69 Parameters of FTMSn: polarity: positive, isolation width: m/z 2 amu, CID energy: 
35 eV, act. Q.: 0.25 and act time: 30 ms.69 
2.3 Isolation of endophytes 
The plants were washed thoroughly in running tap water followed by sterilized water to 
clean all dirt and mud sticking to them.39,96 The healthy tissues were slit into 
approximately 10 × 5 mm pieces by flame-sterilized razor blades.39,96 Then, the small 
fragments were surface-sterilized by successive immersion in 70% ethanol for 1 min, 1.3 
M sodium hypochlorite (3–5% available chlorine) for 3 min, and 70% ethanol for 30 
s.39,96 Finally, these surface-sterilized tissue pieces were rinsed in sterilized water for 1 
min and wrapped by sterilized paper to remove excess water.39,96 Obtained surface 
sterilized tissues were evenly placed on water agar medium in Petri-dishes, then sealed 
with Paraﬁlm® and incubated at 28 ± 2 °C in an incubator until microbial growth 
started.39,96 The procedure of isolation was similar to the experiment reported in 
literature.39,96 To eliminate microbial contaminants from surface and ensure the 
sterilization was completed, the sterilized water used to wash sterilized tissues was sub-
cultured on PDA in parallel. The cultures were monitored every day to check the 
outgrowth of endophytic fungal mycelia or bacterial colonies from plant tissue, after one 
week.39,96 Then the growing endophytic fungi and bacteria were isolated and 
subcultured onto SDA medium and NA medium respectively, and brought into pure 
culture by successive purification if it was necessary.39,96 These isolates were coded 
with abbreviation of plant name and numbers, and then preserved in 20% glycerol 
solution at -80 °C in the microbial library at INFU, TU Dortmund, Germany.69 
3. Identification of isolated fungi and bacteria 
By strictly following the manufacturer’s guidelines, the fungal total genomic DNA (gDNA) 
was extracted from the in vitro cultures using peqGOLD fungal DNA mini kit (cat. no. 12-
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3490-02, Peqlab Biotechnologie GmbH, Erlangen, Germany). The DNA was then PCR 
amplified by primers ITS4 and ITS5 according to the literature.130,232 The amplified 
fragment included ITS1, 5.8S and ITS2 regions of the rDNA.69,130 The PCR reacted in 50 
μL reaction mixture consisting of 1 μL dNTPs (10 mM), 0.5 μL forward primer (100 μM), 
10 μL Phusion HF buffer (5X), 3 μL of template DNA, 0.5 μL reverse primer (100 μM), 
and 1 μL of Phusion polymerase (2U μL-1), and 34 μL of sterile double-distilled 
water.69,130 The PCR cycling setting included an initial denaturation at 98°C for 3 min, 30 
cycles of denaturation, annealing, and elongation at 98°C for 10 s, 58°C for 30 s and 
72°C for 45 s.69,130 This was followed by a final elongation step of 72°C for 10 min.69,130 
Sterile double-distilled water was used as a negative control.69,130 The PCR amplification 
products were checked by gel electrophoresis spanning approximately 500-600 bp 
(base pairs).69,130 According to the manufacturer’s instructions, the PCR products were 
further purified using peqGOLD micro spin cycle pure kit (cat. no. 12-6293-01, Peqlab 
Biotechnologie GmbH, Erlangen, Germany).69,130 The amplified products were then 
sequenced from both sides at GATC Biotech (Cologne, Germany).69,130  
The 16S rRNA analysis of bacteria was following the procedures reported in the 
literature.54 The genomic DNA was extracted from the in vitro cultures using peqGold 
bacterial DNA kit (Peqlab Biotechnologie GmbH, Germany), then subjected to PCR 
amplification using the primers 27f and 1492r.233 The PCR amplification was performed 
in a 50 µL reaction mixture with 45 µL Red Taq DNA Polymerase Master Mix (1.1x), 0.5 
µL reverse primer (100 µM), 0.5 µL forward primer (100 µM), 3 µL template DNA, and 1 
µL of sterile double-distilled water.54 The PCR cycling comprised an initial denaturation 
at 95 °C for 2 min, 30 cycles of denaturation, annealing and elongation at 95 °C for 30 s, 
60 °C for 40 s and 72 °C for 30 s.54 Then a final elongation step was performed at 72 °C 
for 5 min.54 The sterile double-distilled water was used as negative control. The PCR 
amplified products spanning around 1500 bp were checked by agarose gel 
electrophoresis.54 The PCR products were further purified using GFXTM PCR DNA and 
Gel Band Purification kit (GE Healthcare life Sciences, Germany) following 
manufacturer’s instructions.54 The amplified products were then sequenced from both 
directions using primers 27f and 1492r at GATC biotech (Cologne, Germany).54 
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4. Secondary metabolites profiling of endophytes 
4.1 Selection of fermentation conditions 
3 standard pre-screening fermentation conditions were used for secondary metabolites 
screening, namely PDB shaking condition (150 mL broth in 250 mL Erlenmeyer flask, 
150 rpm, 28 °C, 14 days), PDB stationary condition (100 mL broth in 250 mL 
Erlenmeyer flask, 25 ± 2 °C, 16 days), rice medium (solid medium, 10 g rice in 50 mL 
flask, 25 ± 2°C, 30 days). 
4.2 LC-MS analysis of endophytic products  
For broth media, the biomass was extracted by equal volume AcOEt for 24 h at room 
temperature, and the organic layers were separated and concentrated under vacuum in 
40 °C water bath. For the solid media, the biomass was broken by knife and extracted 
by 200 mL AcOEt. Then the AcOEt solution was filtered and concentrated as described 
above.  
The crude extracts were dissolved in 1 mL HPLC grade MeOH, and then diluted for 
1000 times for LC-MS measurement. The solvent system was the same as plant 
fingerprint assay described above. The general gradient was: 0-2 min, 20% acetonitrile; 
2 min-25 min, 20%-80% acetonitrile; 25-27 min, 80-100% acetonitrile; 27-28 min, 100% 
acetonitrile; 28-30 min 100-20% acetonitrile. The MS and MSn settings were the same 
as plant fingerprint assay.  
5. Fungal and bacterial material 
5.1 Endophytic fungus F. solani N06 and endophytic bacterium A. xylosoxidans N12B 
from bulbs of N. tazetta 
After approximately 2 weeks, some visible hyphae tips started to emerge from the plant 
tissues, which were then subcultured and purified on SDA. Endophytic bacterial could be 
seen emerging as oil-drop-like colony from the edge of tissues, which were subcultured 
and purified on NA. The isolated pure colonies of endophytic fungus and bacterium were 
assigned strain codes N06 and N12B respectively. The endophytic fungus F. solani N06 
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has also been submitted to the Leibniz Institute DSMZ – German Collection of 
Microorganisms and Cell Cultures, Braunschweig, Germany, with accession number 
DSM 29858.69 The ITS sequence of F. solani N06 has been deposited at the EMBL-
Bank (accession number LN624513) and the 16s rDNA sequence of A. xylosoxidans 
N12B has also been deposited at the EMBL-Bank (accession number LN810108).69 The 
fermentation of F. solani N06 was in 100 mL stationary PDB broth at 25 °C, in 250 mL 
Erlenmeyer flask.69  
5.2 Endophytic fungi Colletotrichum sp. BS4 and P. capitalensis BS5 and endosynbiotic 
bacterium Herbaspirillum sp. BS5B from leaves of B. sinica 
By the established methods, fungi Colletotrichum sp. BS4 and P. capitalensis BS5 were 
isolated from the leaves of B. sinica, and the endophytic bacterium Herbaspirillum sp. 
BS5B was identified to be an endo hyphal microorganism in P. capitalensis BS5.130,231 
Pure colonies of these two endophytic fungi were preserved in 20% glycerol at -80 °C in 
the internal culture library with assigned strain codes BS4 and BS5 respectively.130,231 
The ITS sequence of the identified endophytic fungus Colletotrichum sp. BS4 and P. 
capitalensis BS5 have been deposited at the EMBL-Bank (accession number LN552210 
and LN828209).130,231 The 16S RNA sequence of Herbaspirillum sp. BS5B has been 
deposited at the EMBL-Bank with accession number LN864763.130 Following the 
reported isolation procedures for the endosymbiotic bacterium,234 however, no free living 
bacterial colony of Herbaspirillum sp. was observed. For Colletotrichum sp. BS4, rice 
medium was used as fermentation medium, at 25 °C, and for P. capitalensis BS5, the 
fermentation condition was the same as strain F. solani N06 mentioned before.130,231 
6. LC-MS
n
 analysis of hexacyclopeptides from F. solani N06 
The 100 mL fermentation broth was extracted 3 times with 300 mL EtOAc at room 
temperature, and the organic layer was evaporated under vacuum in a water bath 
(40 °C) to yield 4 mg semi-dry dark red residues.69 This residue was then re-dissolved in 
500 µL MeOH for LC-HRMS measurement.69 The auto sampler temperature was 10 °C 
and the drawing and ejecting speed were both set to be 200 µL/min.69 For the optimized 
LC condition, 30%−40% gradient acetonitrile aqueous solution with 0.1% formic acid 
was used as mobile phase (linear gradient program: 0−1 min, 30%; 1−26 min, 
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30%−40%; 26−27 min, 40%−100%; 27−30 min, 100%; 30−31 min, 100%−30%; 31−32 
min, 30%).69 Parameters of ion trap MSn: positive mode, isolation width: m/z 2 amu, CID 
energy: 35 eV, act. Q.: 0.25 and act time: 30 ms.69 From the MS3 in FTMS mode, I did 
not obtain enough ion abundance for some peaks, but the MS2 spectra in FTMS mode is 
attached in Chapter 8, Figure S10.69 
7. Purification of target compounds 
7.1 Azaphilones from Colletotrichum sp. BS4 
The large-scale fermentation was performed on solid rice medium (80 g rice, 100 mL 
water, in each 1000 mL flask) at 25 °C with PDB culture as seed broth. After 30 days, 
the culture (1.6 kg) was extracted with 4 L EtOAc at room temperature 3 times to yield 
33 g brown residue after removing the solvent under vacuum.231 This extract was 
subjected to a silica gel column (2  10) cm, and eluted by a stepwise 
cyclohexane/EtOAc gradient from ratio 1:0 to 0:1 into 4 fractions (Fr. 1−Fr. 4).231 Fr. 3 
was eluted on a silica gel column with CH2Cl2/EtOAc (3:1) to obtain two subfractions (Fr 
3a, 3b).231 Successive purification of Fr. 3a by semi-preparative HPLC (UV detection at 
355 nm, flow rate 3 mL/min, mobile phase MeCN and H2O (0.1% formic acid) yielded 5 
mg colletotrichone A (10), (33% MeCN, Rt: 31.8 min), 10 mg colletotrichone B (11a) (45% 
MeCN, Rt: 27.6 min), 2 mg colletotrichone C (12) (55% MeCN, Rt: 25.0 min), 2 mg 
colletotrichone D (60% MeCN, Rt: 21.5 min) and 8 mg chermesinone B (14a) (45% 
MeCN, Rt: 32 min).
231  
Colletotrichone A (10): Colorless amorphous powder; []20D +340.4 (c 0.05, MeOH); 
LC-UV [(acetonitrile in H2O/0.1% FA)] max 222, 340 nm; IR (film) vmax 3368, 2917, 2849, 
1741, 1653, 1612, 1081, 1060 cm-1; CD spectrum (0.1 mg/mL, MeOH), 200 (∆ε -1.85), 
213 (∆ε +0.66), 256 (∆ε -8.23), 326 nm (∆ε +10.21); 1H NMR (CD3OD, 500 MHz) and 
13C NMR (CD3OD, 125 MHz), see Table 3 and 4. ESI-HRMS m/z: 349.1280, [M+H]
+ 
(calcd for C18H21O7, 349.1282, ∆ -0.5108 ppm), 366.1547, [M+NH4]
+ (calcd for 
C18H24O7N, 366.1547, ∆ -0.0934 ppm).
231 
X-ray crystallographic analysis of colletotrichone A (10): Diffraction experiment was 
performed on an Oxford Diffraction Xcalibur S diffractometer with graphite 
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monochromated Mo-Kα radiation (λ = 0.71073 Å).231 The crystal structures were solved 
with direct methods (SHELXS97) and refined against F2 with the full-matrix least-
squares method (SHELXL97).231,235 A multi-scan absorption correction using the 
CrysAlis RED program (Oxford Diffraction, 2006) was employed.231 The non-hydrogen 
atoms were placed in geometrically calculated positions and each was assigned a fixed 
isotropic displacement parameter based on a riding-model.231 
A colorless crystal was obtained from a solution of EtOAc: MeOH (1:1, v/v), 
orthorhombic crystal system; space group P21212; a = 15.0896(7) Å, b = 15.6838(7) Å, c 
= 7.1843(3) Å, α = β = γ = 90°, V = 1700.25(13) Å3; Z = 4, d = 1.361 g/cm3; crystal 
dimensions 0.12 × 0.09 × 0.04 mm; the final indices were R1 = 0.0346, wR2 = 0.0796.
231 
Crystallographic data of colletotrichone A (1) was deposited in the Cambridge 
Crystallographic Data Centre with supplementary publication number CCDC 1013027. 
Copies of the data can be obtained, free of charge, on application to the Director, 12 
Union Road, Cambridge CB2 1EZ, UK (fax: +44(0)1223 336033 or by e-mail: 
deposit@ccdc.cam.ac.uk).231 
Colletotrichone B (11a): Yellowish oil; []20D +81.0 (c 1.29, CHCl3); LC-UV [(acetonitrile 
in H2O/0.1% FA)] max 222, 366 nm; IR (film) vmax 3453, 2968, 2929, 1773, 1623, 1550, 
1088 cm-1; CD spectrum (0.1 mg/mL, MeOH), 209 nm (∆ε -1.63), 254 (∆ε +1.89), 327 
(∆ε +8.19), 361 (∆ε -4.81), 373 nm (∆ε -4.86); 1H NMR (CDCl3, 500 MHz) and 
13C NMR 
(CDCl3, 125 MHz), see Table 3 and 4; 
1H NMR (acetone-d6, 500 MHz) and 
13C NMR 
(acetone-d6, 125 MHz), see Table 5. ESI-HRMS m/z: 317.1385, [M+H]
+ (calcd for 
C18H21O5, 317.1384, ∆ 0.3609 ppm).
231  
Colletotrichone C (12): Colorless amorphous powder; []20D +124.2 (c 0.07, CHCl3); LC-
UV [(acetonitrile in H2O/0.1% FA)] max 214, 332 nm; IR (film) vmax 2971, 2933, 1779, 
1711, 1612, 1219, 1105, 1029 cm-1; CD spectrum (0.1 mg/mL, MeOH), 202 (∆ε +2.45), 
224 (∆ε -0.26), 250 (∆ε +2.28), 286 (∆ε -0.67), 344 nm (∆ε +3.64); 1H NMR (CDCl3, 500 
MHz) and 13C NMR (CDCl3, 125 MHz), see Table 3 and 4. ESI-HRMS m/z: 319.1542, 
[M+H]+ (calcd for C18H23O5, 319.1540, ∆ 0.7083 ppm), 341.1361, [M+Na]
+ (calcd for 
C18H22O5Na, 341.1359, ∆ -0.5143 ppm), 659.2836, [2M+Na]
+ (calcd for C36H44O10Na, 
659.2827, ∆ 1.4080 ppm).231 
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Colletotrichone D (13): Colorless amorphous powder; []20D +139.58 (c 0.14, CHCl3); 
LC-UV [(acetonitrile in H2O/0.1% FA)] max 226, 344 nm; IR (film) vmax 3394, 2966, 2934, 
1718, 1646, 1268, 1241, 1113 cm-1; CD spectrum (0.1 mg/mL, MeOH), 200 (∆ε +2.59), 
237 (∆ε -1.89), 326 (∆ε +4.67); 1H NMR (CDCl3, 500 MHz) and 
13C NMR (CDCl3, 125 
MHz), see Table 7. ESI-HRMS m/z: 363.1439, [M+H]+ (calcd for C19H23O7, 363.1438, ∆ 
0.2490 ppm), 380.1699, [M+NH4]
+ (calcd for C19H26O7N, 380.1704, ∆ -1.2060 ppm).
231 
7.2 Lactam-fused 4-pyrones from endosymbiotic community of P. capitalensis BS5 and 
Herbaspirillum sp. 
The large-scale fermentation was performed in 10 L static PDB medium at 25 °C. After 
60 days, the broth and mycelium was extracted with 10 L EtOAc at room temperature 3 
times.130 The EtOAc solution was evaporated under vacuum to yield 930 mg dark brown 
residue.130 The residue was dissolved in 70% MeOH and washed by n-hexane.130 The 
70% MeOH layer was concentrated and subjected to C18 SPE column then eluted by 
water, 60% MeOH, and 100% MeOH successively.130 The 60% MeOH eluates were 
collected and evaporated to yield 229 mg residues (Fr. B).130 From Fr. B, 10 mg 
phyllostictalactam A (15) was purified on HPLC system with mobile phase 55% MeOH 
and 3 mL/min flow rate (Rt: 25.0 min).
130  
Phyllostictalactam A (15): Colorless amorphous powder; []20D ≈ 0 (c 0.117, MeOH); LC-
UV [(acetonitrile in H2O/0.1% FA)] max 218, 314 nm; IR (film) vmax 3284, 2925, 2839, 
1709, 1646, 1565, 1081, 675 cm-1; CD spectrum (0.1 mg/mL, MeOH), no Cotton effect 
observed; 1H NMR (acetone-d6, 500 MHz) and 
13C NMR (acetone-d6, 125 MHz), see 
Table 10. ESI-HRMS m/z: 266.1024, [M+H]+ (calcd for C13H16O5N, 266.1023, ∆ 0.4431 
ppm), 283.1290, [M+NH4]
+ (calcd for C13H19O5N2, 283.1288, ∆ 0.6363 ppm).
130 
8. Bioactivity assays for isolated pure compounds 
8.1 Disc diffusion antibacterial assay 
This part of work was performed based on the established methods reported in the 
literature.78 The agar plates were prepared with 90 mm diameter Petri-dishes and 
approximately 22 mL melted NA solution.78 The assay strains of bacteria were 
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inoculated in NB medium for 24 h at 37 °C with shaking speed 150 rpm.78 Then 200 µL 
bacterial suspensions were spread on each agar plates evenly.78 Parallelly, 40 µL 
MeOH solution of each candidate compound was dropped on paper dishes and then 
dried in the clean bench under the laminar airflow hood, to avoid airborne 
contamination.78 The paper dishes were placed on the inoculated agar plates with 
sufficient distance, and on each agar plates, there were three duplicates of each 
concentration of compounds.78 Then the agar plates were stored at 4 °C for 2 h to 
enable the compounds to diffuse on the agar surface before the bacteria started to 
grow.78 Afterward, the agar plates were incubated at 37 °C for 24 h.78 The blank control 
was pure MeOH and the positive control was streptomycin and gentamicin.78 The 
inhibitory activity of candidate compounds was determined by observable inhibitory zone 
surrounding paper dishes.78  
8.2 Cytotoxic assay 
A 50 mM stock solution was prepared for each compound (10, 11a, 12 and 14a) in 
DMSO and filter-sterilized through 0.2 μm filter under vacuum.51 From the stock solution, 
working concentrations were prepared with a dilution factor (DF) of 3 to reach a 
maximum concentration of 100 μM.51 The in vitro cytotoxicity of each compound against 
the human cancer cell line THP-1 was determined (48 h exposure) using 96-well flat 
bottom tissue culture plates (black) using two established methods51 in parallel using a 
VICTOR multilabel plate reader (PerkinElmer Life And Analytical Sciences, Inc., Boston, 
MA).51 The first method consisted of quantification using resazurin (Sigma-Aldrich 
Chemie GmbH), to measure the mitochondrial activity.51 The second method consisted 
of quantification using ATPlite (PerkinElmer Life and Analytical Sciences, Inc.), to 
measure the available ATP concentration.51 The final relative viabilities were calculated 
and represented in percent fractional survival (FS).51  
Culturing of the THP-1 Cell Line. The human acute monocytic leukemia cell line (THP-1), 
with DSMZ number ACC 16, was used.51 The THP-1 cells were grown in tissue culture 
flasks in complete growth medium in an atmosphere of 5% CO2 and 90% relative 
humidity in a carbon dioxide incubator.51 The complete growth medium was prepared by 
using RPMI-1640 supplemented with 2 mM L-glutamine, 10% FBS, and penicillin (100 
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IU mL-1, just before use) in double-distilled water.51 The pH of the medium was adjusted 
to 7.2, and the medium was sterilized by filtering through 0.2 μm filters in a laminar air 
flow hood under aseptic conditions.51 
Subculturing of the THP-1 Cell Line. For subculturing, the medium of the flask having 
subconfluent growth was changed 1 day in advance. The entire medium from the flask 
was taken out and discarded. Cells were washed with PBS.51 Thereafter, 0.5 mL of 
Trypsin-EDTA in PBS (pre-warmed at 37 °C) was added to make a thin layer on the 
monolayer of the THP-1 cells.51 The flask was incubated for approximately 5 min at 
37 °C and observed under a microscope.51 If the cells were found to be detached, 
complete growth medium (1 mL, pre-warmed at 37 °C) was added to make the cell 
suspension. An aliquot was taken out and cells were counted and checked for viability 
with Trypan blue.51 Cell stock of more than 98% cell viability was accepted for 
determination of the in vitro cytotoxicity.51 The cell density was adjusted to 7.5 × 104 
cells mL-1 by addition of a complete growth medium.51 
9. Quantum chemical computation 
For the azaphilones (10−12, 14) isolated from Fungus Colletotrichum sp. BS4: 
The conformer candidates were searched with the MMFF force field routine of 
Spartan'14 (Wavefunction, Inc.: Irvine, CA, 2014).236 The geometries of all obtained 
conformers within 25 kJ/mol above the global minimum were optimized on wB97X-D/6-
31+G(d) level of theory. The resulted geometries were directly used for NMR spectra 
calculation with EDF2/6-31G*; the final Boltzmann factors were obtained with wB97X-
D/6-311+G(2df,2p), using Gaussian g09.231,237 The NMR shifts of all remaining 
conformers were averaged with respect to their final Boltzmann factors. ECD calculation 
was performed on wB97X-D/6-311G(d,p) based on the optimized geometries and the 
Boltzmann factors. The ORD spectrum was calculated on wB97X-D/6-311G(d,p) level of 
theory. 
For Colletotrichone D (13) isolated from Fungus Colletotrichum sp. BS4 
Frog2 online version was used for conformational searches with 50 kcal/mol energy 
window, 1000 maximum steps and 100 kcal/mol maximum energy.238 The optimization 
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and frequency calculations of all obtained conformers were performed with GAMESS 
2014 R1239 on B3PW91-D3/6-31G(d)240,241 level of theory with C-PCM solvent model. 
13C NMR GIAO shielding constants calculation on mPW1PW91/6-31+G(d) level of 
theory and ECD calculation on mPW1PW91/pcSeg-1242 level of theory were performed 
on Dalton 2015,243 with IEF-PCM solvent model.244 ECD curves were simulated by 
Gaussian function according to formula 8d in literature.245  
For the lactam-fused 4-pyrones from Fungus Phyllosticta capitalensis BS5 and 
endosymbiotic bacterium Herbaspirillum sp. BS5B: 
Frog2 online version was used for conformational searches with 100 kcal/mol energy 
window, 1000 maximum steps and 100 kcal/mol maximum energy.130,238 The 
optimization and frequency calculations of all obtained conformers were performed with 
GAMESS 2014 R1239 on B3PW91-D3/6-311G(d,p)240,241 level of theory with C-PCM 
solvent model.130 13C NMR GIAO shielding constants calculation was performed on 
Dalton 2015 on mPW1PW91/6-31+G(d) level of theory,243 with IEF-PCM solvent 
model.130,244  
10. MALDI IMS 
10.1 Sample preparation 
All samples were growing colony cut from agar medium. 18 × 18 × 1 mm glass plates 
were used as sample holder for the measurement.69 After the detection areas were 
placed on the glass plates, the agar layers were dried by oil pump at room temperature 
slowly.69 The matrix solution used was HCCA (7 mg/mL) in acetonitrile : water 1 : 1 (v/v) 
with additional 0.2% organic acid (TFA for the experiment of F. solani and A. 
xylosoxidans, and FA for the experiment of Colletotrichum sp. BS4).69 The matrix 
solution was sprayed with the following parameters: 50 rpm sample plate revolution 
speed, 4.5 L/min gas (N2) flow rate, 10 µL/min matrix flow rate, and 3 × 10 min spray 
cycle and duration.69 The sample glass plates were recorded by microscope before and 
after spray application, and the regions for measurement were marked for locating the 
measured areas.246  
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9.2 Measurement parameters 
Scan resolution was adjusted to 60 µm, the scan was taken from a rectangular region 
via full scan in the positive ion mode with internal lock mass correction (mass: m/z 
379.09246 [2M+H]+, HCCA).69 Mass range was m/z 300−800 for the experiment of 
hexacyclopeptides, and was m/z 100−800 for the experiment of azaphilones. The 
resolution of mass spectra was adjusted to be 140,000 @ m/z 200.69 And the S-lens 
level was set to be 65 with a spray voltage of 2.0 kV and injection time of 200 ms. Laser 
beam attenuator value was 20°.69 The software package for data processing and 
generation of ion density images was ImageQuest v. 1.1.0 (Thermo Fisher 
Scientific).69,246  
11. Synthesis  
11.1 Synthesis of precursor α-deuterated amino acids 
This part of the experiment was applied for amino acid leucine, isoleucine, valine, 
alanine, and proline, with more than 90% deuterium purity for α-position (checked by 1H 
NMR and MS). 0.1 mM amino acid, 3 µL anisaldehyde were dissolved in 1 mL AcOD. 
Then the solution was stirred and heated in 95 °C oil bath for 3 h before concentrated 
under vacuum.247 Then the residue was dissolved in water and washed by EtOAc. The 
water layer was evaporated under vacuum to yield α-deuterated amino acids. 
11.2 Synthesis of 2,4,4,4-tetradeuterium-threonine 
Anhydrous CuCl2 was prepared by dehydration of 34 mg CuCl2·2H2O in 110 °C oven for 
1 h, and then sealed and cooled down to r. t. and then dissolved in 1 mL D2O.
69 Thereby, 
20 mg glycine and 100 µL triethylamine were added into this solution, which was stirred 
at 50 °C for 2 h.69 After the solution was cooled down at 0 °C, 112 µL acetaldehyde was 
added and it was stirred for 3 h more and then temperature was increased to r. t. for 
another 14 h.69 Afterwards, the solution was concentrated under vacuum and then 
subjected on 0.5 cm × 2 cm DowexTM 50WX8-100 CC ion-exchange resin column, and 
washed by deionized water and 2.5% NH3•H2O solution 15 mL successively.
69 The 
eluate of NH3•H2O solution was collected and concentrated under vacuum and then 
washed by EtOH to yield 11 mg 2,4,4,4-tetradeuterium-threonine (35% yield).69  
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11.3 Synthesis of 4-OH-4-deuterium-proline 
A 0.3 mM N-Boc-4-oxo-L-proline methyl ester was dissolved in 3 mL MeOH, and the 
solution was cooled down at 0 °C. After 0.6 mM NaBD4 was added, the solution was 
stirred for 3 h and then stirred for 24 h at r. t. Afterwards, the solution was evaporated 
under vacuum, and the residue was dissolved in saturated NH4Cl and extracted by 
AcOEt. The AcOEt layer was separated and washed by brine and dried by anhydrous 
MgSO4. Then AcOEt was removed under vacuum to yield 60 mg N-Boc-4-OH-4-
deuterium-L-proline methyl ester (81% yield).248 0.24 mM N-Boc-4-OH-4-deuterium-L-
proline methyl ester was dissolved in 2 mL 6 M HCl solution, and stirred for 2 h at r. t. 
Then the solution was evaporated under vacuum and re-dissolved in 1 mL de-ionized 
water. The water solution was subjected on 0.5 cm × 2 cm DowexTM 50WX8-100 CC 
ion-exchange resin column, and washed by water and 2.5% NH4OH solution 
successively. The 2.5% NH4OH solution eluate was collected and concentrated under 
vacuum to yield 25 mg 4-OH-4-deuterium-proline (80% yield).248  
11.4 Semi-synthesis of compound 16 from compound 15 
5 mg compound 15 was dissolved in 600 µL CF3COOH / AcOEt (1 : 4, v/v) and stirred 
for 24 h at r. t.130 And then the brown reacted solution was evaporated under vacuum in 
40 °C water bath, yielding approximately 5 mg brown gum (90% yield, checked by LC-
MS), then it was measured by 1H NMR and LC-MSn, and the product had identical 
retention time, UV spectrum and MS2 spectrum with compound 16 in crude extraction of 
fungus Phyllosticta capitalensis BS5 and endosymbiotic bacterium Herbaspirillum sp. 
BS5B in stationary PDB medium.130 LC-UV [(acetonitrile in H2O/0.1% FA)] max 218, 260, 
300, 338 nm; 1H NMR (acetone-d6, 500 MHz): 6.77 (1H, dd, J = 16.1, 7.5, H-9), 6.66 (1H, 
d, J = 16.1, H-10), 5.55 (1H, br s, Ha-8), 5.27 (1H, br s, Hb-8), 2.34 (2H, dt, J = 7.4, 7.4, 
CH2-11), 1.57 (2H, tq, J = 7.4, 7.4, CH2-12), 0.99 (3H, t, J = 7.4, CH3-13). ESI-HRMS 
m/z: 248.0917, [M+H]+ (calcd for C13H14O4N, 248.0917, ∆ -0.3319 ppm), 265.1182, 
[M+NH4]
+ (calcd for C13H17O4N2, 265.1183, ∆ -0.3354 ppm).
130 
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12. Detection of fungal and bacterial polyketide synthase 
(PKS) 
The total genomic DNA (gDNA) was subjected to PCR amplification of genes encoding 
the ketoacyl synthase (KS) domain essential for fungal and bacterial polyketide 
synthesis using previously established primers.249–251 The PCR reaction was performed 
in 50 μL reaction mixture containing 45 μL Red Taq DNA Polymerase Master Mix (1.1x), 
0.5 μL forward primer (100 μM), 0.5 μL reverse primer (100 μM), 3 μL template DNA and 
1 μL of sterile double-distilled water.130 The PCR cycling protocol consisted of an initial 
denaturation at 95oC for 2 min, 30 cycles of denaturation at 95 oC for 30 s, annealing at 
44 oC (for fungal PKS) and 59 oC (bacterial PKS) for 40 s and elongation at 72 oC for 30 
s.130 This was followed by a final elongation step at 72 oC for 5 min.130 As a negative 
control, the template DNA was replaced by sterile double distilled water.130 As a positive 
control, the genomic DNA of Bacillus subtilis (DSM 1088) and Aspergillus versicolor 
(Isolate A12; EMBL accession number HE962600)252 was used.130 The PCR amplified 
product spanning approximately 700 bp for both fungal and bacterial PKS were checked 
by gel electrophoresis and purified using GFXTM PCR DNA and Gel Band Purification kit 
(GE Healthcare Life Sciences, Germany) following manufacturer’s instructions.130 The 
amplified products of positive sequences were then sequenced from both directions at 
Seqlab Sequence Laboratories (Göttingen, Germany).130 
13. Detection of fungal and bacterial nonribosomal peptide 
synthetase (NRPS) 
The total genomic DNA (gDNA) was subjected to PCR amplification of genes encoding 
the adenylation domain (A domain) domain essential for fungal and bacterial 
nonribosomal peptide synthesis using previously established primers.251,253,254 The PCR 
reaction was performed in 50 μL reaction mixture containing 45 μL Red Taq DNA 
Polymerase Master Mix (1.1x), 0.5 μL forward primer (100 μM), 0.5 μL reverse primer 
(100 μM), 3 μL template DNA and 1 μL of sterile double-distilled water.130 The PCR 
cycling protocol consisted of an initial denaturation at 95 oC for 2 min, 30 cycles of 
denaturation at 95 oC for 30 s, annealing at 44 oC (for fungal NRPS) and 46 oC (bacterial 
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NRPS) for 40 s and elongation at 72 oC for 30 s.130 This was followed by a final 
elongation step at 72 oC for 5 min.130 As a negative control, the template DNA was 
replaced by sterile double distilled water.130 As a positive control, the genomic DNA of 
Bacillus subtilis (DSM 1088) and Aspergillus versicolor (Isolate A12; EMBL accession 
number HE962600) was used.252 The PCR amplified product spanning approximately 
300 bp for fungal and 1000 bp for bacterial NRPS were checked by gel electrophoresis 
and purified using GFXTM PCR DNA and Gel Band Purification kit (GE Healthcare Life 
Sciences, Germany) following manufacturer’s instructions.130 The amplified products of 
positive sequences were then sequenced from both directions at Seqlab Sequence 
Laboratories (Göttingen, Germany).130 
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1. Chemical crosstalk between endophytic fungi F. solani N06 
and endophytic bacteria via new hexacyclopeptides 
1.1 Metabolites screening of F. solani N06 
Based on the “OSMAC” (One Strain Many Compounds) strategy,255 the endophytic 
strain F. solani N06 was cultured in different conditions, which were combined by 
several viable parameters, such as different media with diverse carbon/nitrogen sources 
including liquid media (PDB, SDB) and solid rice medium, different shaking condition like 
stationary state or rotating state with speed 150 rpm, and different temperature (25 °C or 
29 °C). This screening step was also the routine approach for other strains mentioned 
herein. In the stationary PDB broth and PDA agar medium, a series of 
hexacyclopeptides were detected by LC-MS measurements (Table 2, Figure 9).69 These 
hexacyclopeptides could also be produced in stationary SDB medium with smaller 
amount. 
Table 2. Retention time and adducts ion intensity of compounds 1−9 (∆ < 2 ppm) 
Compound 
r. t. 
(min) 
m/z of adducts (Maximum intensity) 
[M+H-2H2O]
+ [M+H-H2O]
+ [M+H]+ [M+NH4]
+ [M+Na]+ [M+K]+ 
1 
C30H52O8N6 
4.46 589.3708 
(6.69E4) 
607.3814 
(2.50E6) 
625.3919 
(6.15E5) 
n. d. 647.3739 
(1.37E6) 
663.3478 
(2.53E5) 
2 
C30H52O8N6 
8.20 589.3708 
(3.89E5) 
607.3814 
(1.80E5) 
625.3919 
(5.28E3) 
n. d. 647.3739 
(3.89E5) 
663.3478 
(3.31E4) 
3 
C30H52O8N6 
9.89 589.3708 
(4.14E6) 
607.3814 
(2.03E6) 
625.3919 
(9.71E3) 
n. d. 647.3739 
(2.52E4) 
663.3478 
(2.54E3) 
4 
C30H52O8N6 
11.24 589.3708 
(1.98E6) 
607.3814 
(1.16E6) 
625.3919 
(2.50E3) 
n. d. 647.3739 
(1.27E4) 
n. d. 
5 
C30H50O7N6 
13.42 n. d. 589.3708 
(1.16E5) 
607.3814 
(3.22E6) 
624.4079 
(3.42E5) 
629.3633 
(1.06E6) 
645.3372 
(1.42E5) 
6 
C32H56O8N6 
10.43 617.4021 
(2.14E4) 
635.4127 
(9.25E5) 
653.4232 
(3.47E5) 
670.4498 
(6.85E3) 
675.4052 
(5.88E5) 
691.3791 
(7.61E4) 
7 
C32H56O8N6 
18.49 617.4021 
(4.04E6) 
635.4127 
(1.68E6) 
653.4232 
(4.98E3) 
n. d. 675.4052 
(7.61E3) 
n. d. 
8 
C32H56O8N6 
19.01 617.4021 
(1.73E6) 
635.4127 
(8.98E5) 
653.4232 
(3.27E3) 
n. d. 675.4052 
(4.66E3) 
n. d. 
9 
C32H54O7N6 
22.07 n. d. 617.4021 
(1.02E5) 
635.4127 
(1.87E6) 
652.4392 
(1.74E5) 
657.3946 
(5.65E5) 
673.3686 
(7.72E4) 
a n. d., not detected 
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Figure 9. LC-MS positive full scan chromatogram of hexacyclopeptides (1−9) from F. 
solani in static PDB medium69 
1.2 Strategy to investigate the new hexacyclopeptides 
Significant degeneration of the production of these hexacyclopeptides was observed 
during sub-culture or even growth process of this strain, which caused that the large 
scale fermentation for these compounds was not possible.69 This biosynthetic 
attenuation could not be restored either by co-culturing it with other endophytes 
(including the endophytic bacterium A. xylosoxidans N12B isolated from the same bulb 
tissue), or by addition of plant extracts or amino acid precursors into the culture media, 
or by other modifications of fermentation conditions.69 Thus far, accumulation of more 
compounds could not be achieved in vitro just by tweaking the culture conditions or 
increasing the volume of media, thereby preventing us from purifying them by 
chromatography and identifying them by established structure elucidation techniques 
such as 1D and 2D NMR.69 For the currently available techniques for natural products 
discovery, the lower limit is around 10 µg,256,257 which is, in fact, a barrier keeping us 
from elucidating trace compounds produced by endophytes.69  
In this case, therefore, a “location dictates function” strategy was adopted to utilize 
MALDI-imaging-HRMS and LC-HRMSn to elucidate our target functional molecules and 
investigate their structureal information.69 On MALDI plates (18 × 18 × 1 mm), 
endophytes can grow into visible colonies suitable for detection in 1 or 2 days, which 
enables us to study the production and temporal release of our target compounds 
produced by endophytes from the time after their isolation up to 48 h (before some 
plausible biological changes occurred in laboratory conditions).69 The spatial and 
temporal distribution of potential biofunctional compounds provided by MALDI-imaging-
HRMS helped us to efficiently target specific compounds.69 And the structure elucidation 
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of hexacyclopeptides can be achieved by LC-MSn technique, which requires only small 
quantity of compounds.69  
1.3 Visualization of hexacyclopeptides in the dual culture of F. solani N06 and A. 
xylosoxidans N12B by MALDI IMS 
We used the MALDI-imaging-HRMS to investigate the small molecular metabolites 
produced by endophytic F. solani N06 and their spatial as well as temporal distribution 
up to 48 h, and attempted to reveal the chemical crosstalk between this fungus and 
other endophytic microorganisms harbored the same bulb tissue.69 MALDI imaging with 
lateral resolution of 60 µm enabled us to assemble the chemical information in subtle 
parts of the endophytic microorganism’s colony over a period of 2 days.69  
 
Figure 10. Distribution visualization of hexacyclopeptides (1−9) by MALDI IMS after 48 
h. a Optical image of F. solani N06. b TIC (m/z 300−800) of detected area. c Ion 
intensity map of C30H52O8N6Na. d Ion intensity map of C32H56O8N6Na
69 
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Figure 11. Distribution visualization of hexacyclopeptides detected in MALDI-imaging-
HRMS scan of the endophytic fungus F. solani and another endophytic bacterium A. 
xylosoxidans isolated from the same plant tissue after 48 h. a Optical image of the 
boundary area between F. solani and bacterium A. xylosoxidans. b TIC (m/z 300−800) 
of detected area. c Ion intensity map of C30H52O8N6Na. d Ion intensity map of 
C32H56O8N6Na
69 
We measured the strain F. solani N06 alone (Figure 10) and F. solani co-cultured with 
the endophytic bacterium A. xylosoxidans N12B from the same tissue on PDA (Figure 
10).69 In our preliminary study, a group of interesting compounds was observed to be 
gradually secreted from the fungal colony to surrounding media. Moreover, they were 
accumulated by a specific part of the bacterial colony closest to fungal mycelia, while the 
intensity of the nearby region was much lower than the region without bacterium (see 
Figure 10 and 11 for measurements done after 48 h).69 It was particularly interesting to 
note that the endophytic bacterium could selectively accumulate the hexacyclopeptides 
produced and secreted by the endophytic fungus into the agar (Figure 10c,d).69 At 
regions where the bacterium was absent, the hexacyclopeptides secreted by the 
endophytic fungus diffused uniformly into the agar (Figure 10c,d).69 However, the 
bacterium can expediently accumulate the hexacyclopeptides from its vicinity (see the 
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agar without hexacyclopeptides diffused into it nearby the bacterial colony in Figure 
11c,d).69 Furthermore, the intensity of bacterium-accumulated hexacyclopeptides was 
lower than what was observed in the agar without bacterium (free diffusion), 
corroborating the notion of signal elimination that occurs during ‘neighbor 
communication’ between cells.69,258 
To exclude the interference from any experimental material, I checked the mass of 
targeted molecules in unseeded agar plates sprayed with matrix solution. For mass m/z 
675.4052, there were few interfering signals in blank matrix or blank agar.69 However, 
mass m/z 647.3739 was also found in blank agar with relatively lower intensity (Chapter 
8, Figure S12).69 Therefore, I increased the lower limit of the intensity scale during data 
processing of the ion density images in order to reduce the background signal.69 The 
EtOAc extracts of blank agar medium and the agar medium with the fungus F. solani 
were measured with LC-HRMS/MS, and I excluded the existence of these 
hexacyclopeptides in blank agar and proved that the target compounds were identical 
with those detected in static PDB medium.69 It was notable that the hexacyclopeptides 
were released by the cultured endophytic fungus into the agar in line with what was 
observed (visualized) in our MALDI-imaging-HRMS experiments (see Figure 10 and 
11).69  
1.4 Structure elucidation of hexacyclopeptides (1−9) by LC-MSn 
In MALDI-imaging-HRMS, the ions of one pixel were collected from a small area on the 
surface of the sample,228,259 which led to having their intensity very low.69 Therefore, I 
decided to investigate enriched samples from higher amount of biomass to discover 
smaller amount of isomers or other derivatives by LC-HRMSn.69 Moreover, the 
interference of compounds with the same molecular weight from blank medium could 
also be avoided by LC separation.69 
After screening several media compositions, along with fermentation parameters such 
as temperature and shaking conditions, I found that static fermentation in PDB medium 
was optimal for culturing F. solani N06 for maximum production of our target 
compounds.69 With the same PDB medium, notably, our target compounds could not be 
produced at all (< LOD) under shaking condition (150 rpm).69 Using an optimized 
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chromatographic condition on LC-HRMS with C18 column, hexacyclopeptides could be 
well-separated into nine peaks (compounds 1−9) (Figure 9).69 I detected four 
compounds with formula C30H52O8N6 (1−4) and a dehydrated product with formula 
C30H50O7N6 (5), as well as three compounds with formula C32H56O8N6 (6−8) and a 
relevant dehydrated product C32H54O7N6 (9) (Table 2).
69 Both for compounds 1−4 and 
6−8, [M+H-H2O]
+ and [M+H-2H2O]
+ were observed by full scan MS, while compounds 5 
and 9 showed only [M+H-H2O]
+, which indicated two hydroxyl-group-containing amino 
acid residues in compounds 1−4 and 6−8, and one in compounds 5 and 9.69  
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Figure 12. MS2 fragments of compounds 1−9 with CID (35 eV). a MS2 of [M+H-2H2O]
+, 
m/z 589.4 (compounds 1−4) and [M+H-H2O]
+, m/z 589.4 (compound 5). b MS2 of [M+H-
2H2O]
+, m/z 617.4 (compounds 6−8) and [M+H-H2O]
+, m/z 617.4 (compound 9)69 
In ITMS mode, [M+H-2H2O]
+ of compounds 1−4 and 6−8, and [M+H-H2O]
+ of compound 
5 and compound 9 were selected for MS2 with CID (35 eV), and they showed typical a, b 
and y ions (Figure 12).69,187 Two different patterns of fragmentation were confirmed by 
further collision of y5 and a2 fragments in MS
3 experiments (Figure 13).69 For 
compounds 5 and 9, the dehydrated amino acid was confirmed to be Dhp residue, 
because I observed a loss of Thr-Xle fragment from parent mass to b4 ion and the y5 ion 
with an intact threonine residue, when I selected [M+H]+ as parent mass for MS2 
measurement (Chapter 8, Figure S10).69 Therefore, the nine hexacyclopeptides were 
identified to be cyclo(Hyp-Xle-Xle-Ala-Thr-Xle) (1−4), cyclo(Dhp-Xle-Xle-Ala-Thr-Xle) (5), 
cyclo(Hyp-Xle-Xle-Val-Thr-Xle) (6−8) and cyclo(Dhp-Xle-Xle-Val-Thr-Xle) (9) (Figure 
12).69  
 
Figure 13. MS3 of y5 ions and a2 ions of compounds 1−9. a y5 ion (m/z 476.2) of 
compounds 1−5. b y5 ion (m/z 504.2) of compounds 6−9. c a2 ion (m/z 181.2) of 
compounds 1−969 
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The difference between the compounds sharing the same formula (1−4 or 6−8) is the 
number of leucine and isoleucine which do not differ by molecular weight.69 In the case 
of compounds with a sum formula C30H52O8N6, a maximum of eight peaks can be 
expected.69 However, I could detect merely four peaks.69 Similarly, in the case of 
compounds with sum formula C32H56O8N6, even though a maximum of eight peaks can 
be expected, I could detect only three peaks (see Table 2).69 To assign the Leu/Ile 
residue, I have tried the method described by Armirotti et al. to observe the 
characteristic 69 Da fragment of isoleucine.260 However, I failed to collect enough ions 
after choosing Leu/Ile containing fragment for secondary collision in MS5 or MS6.69 
Compared to the 500 fmol/µL sample concentration and direct infusion analysis at 5 
µL/min flow rate as reported in the literature, I could obtain far less ion abundance for 
target molecules after LC separation.69 In contrast to this, I also measured the MS3 
spectrum of a standard isoleucine sample, wherein I observed the 69 Da fragment that I 
assigned to C5H9
+ (69.0701, calcd. 69.0699, ∆ 3.4351 ppm) (Chapter 8, Figure S13).69  
1.5 Isotope labeling to verify the biosynthetic origin of hexacyclopeptides 
In order to exclude the possibility that the hexacyclopeptides were introduced or 
assimilated from host plant or artificial environment (media contaminants, etc.), I 
performed an isotope labeling experiment to verify the biosynthesis of these compounds 
by the endophytic fungus.69  
First of all, I adopted deuterium exchange reaction to prepare labeled amino acids. The 
racemization reaction of amino acids catalyzed by aromatic aldehydes in deuterated 
acetic acid will readily produce 2-deuterium-amino acids, according to the 
mechanism.247 For the aliphatic amino acids such as Leu, Ile, Pro, Ala, and Val, 2-
deuterium amino acids were prepared with high percentages of deuterium and decent 
yields. However, threonine was not stable in the racemization condition and no product 
was obtained in this reaction. 10 mg of each yielded precursor amino acid was then 
injected into the medium through 0.22 µm sterile MILLEX®-GP filter on the fourth day of 
fermentation (final concentration: 100 mg/L). The feeding experiment of 2-deuterated 
Leu, Ile, Pro, Ala and Val didn’t introduce deuterium in the final hexacyclopeptide 
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products. The reason is probably the transaminase in the fungal cells, which removed 
the 2-deuterium in the fed amino acids.261  
Therefore, I designed other reactions to label amino acids other than α position. The 
2,4,4,4-tetradeuterium-threonine (Chapter 8, Figure S6 and S7) was synthesized with a 
method similar to the one described in the literature (Figure 14).262 However, I avoided 
the active proton containing reagents and instead used D2O to exchange the α-protons 
of acetaldehyde and glycine, and the base was changed from NaOH to TEA.69 After 
feeding 10 mg obtained 2,4,4,4-tetradeuterium-threonine as described above, the LC-
HRMS analysis of the broth showed labeled threonine was incorporated in these 
hexacyclopeptides (Figure 16).69 However, one of the deuterium label was almost lost, 
which confirmed that the deuterium at 2-position can be removed by transaminases.261 
The label of threonine verified that these hexacyclopeptides were indeed synthesized by 
the endophytic fungus F. solani N06.69  
 
Figure 14. Synthesis of 2,4,4,4-tetradeuterium-threonine69 
4-OH-4-deuterium-proline was synthesized by reduction of N-Boc-4-Oxo-L-proline 
methyl ester with NaBD4 followed by hydrolysis (Figure 15). Notably, the fed 4-OH-4-
deuterium-proline could not be detected in the hexacyclopeptides, which suggests that 
4-OH-4-deuterium-proline is not the building block in the NRPS bio-synthesis. The 4-OH 
proline residue in hexacyclopeptides was probably modified after NRPS biosynthesis or 
the OH-proline residue is 3-OH-proline (uncommon in natural products). 
 
Figure 15. Synthesis of 4-OH-4-deuterium-proline 
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Figure 16. The MS of labeled hexacyclopeptides in feeding experiment with 2,4,4,4-
tetradeuterium-threonine. a Labeled compounds 1−4. b Labeled compound 5. c Labeled 
compounds 6−8. d Labeled compound 969 
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Further labeling experiment was not continued because the stock in -80 °C storage of 
the first generation fungus was limited. The effort to isolate the same fungus from plant 
tissue will be included in future research. 
1.6 Discussion 
The novel behavior of the hexacyclopeptides reported in this manuscript between 
endophytic F. solani and the endophytic bacterium A. xylosoxidans N12B harbored in 
the same host plant tissue demonstrates a proof-of-concept of endophyte-endophyte 
interspecies neighbor communication.18,69 This interesting phenomenon upholds the 
analogous behaviors of other signal molecules reported earlier such as AI-2215 and α-
factor,258 which can be taken up and/or eliminated from extracellular environment by 
sensing cells in the crosstalk with each other.69,263 Remarkably, strains of A. 
xylosoxidans are well known as exhibiting various microbial crosstalk strategies 
including the ability to form biofilms, be motile and produce a plethora of virulence 
factors.69,264 Incidentally, in an earlier study, a strain of A. xylosoxidans F3B, was not 
only shown to be endophyte in Arabidopsis thaliana, but also to tolerate selected 
pollutants and aid in phytoremediation.69,105 Thus far, within the contexts of plant-
microbe and microbe-microbe interactions (including endophytes), our results add 
further novel insights to the plethora of mutualistic, defensive and synergistic 
functionalities of plant and microbial peptides reported in the last decade.69,265,266 During 
the process of evolution, endophytes generally establish one or more communication 
strategies with their host plant as well as with other coexisting endophytes to survive and 
function in their distinct ecological niches.54,69 These strategies often include triggers or 
inducers to initiate the pathway(s) of certain metabolites.18,69 In the present case, the 
production of target hexacyclopeptides diminished gradually after the endophytic F. 
solani was separated from its ‘natural’ ambient within the host plant tissue.69 Surprisingly, 
albeit in line with several former investigations, the trigger could not be transferred to in 
vitro conditions only by adding extracts from the host plant or tweaking the fermentation 
media or conditions.69  
To reveal the ‘cryptic’ natural products that cannot be produced under artificial 
conditions, genome-based natural product discovery is developing rapidly, wherein 
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numerous compounds are being discovered that remained unexploited earlier.69,267–269 
However, complete or, at least, partial sequencing of the target microorganism is an 
integral prerequisite for gene analyses and prediction of the biosynthetic products.69,267–
269 On one hand, MALDI-imaging-HRMS not only revealed the spatial and temporal 
distribution of functional molecules but also showed an unparalleled advantage in the 
investigation of interspecies interaction.69 On the other hand, LC-HRMSn enabled us to 
analyze relatively concentrated samples and gather the information of fragments to 
identify unknown compounds.69 The combination of the two tools can be a 
supplementary approach to discover new functional natural products from endophytes 
and ascertain their plausible functions in their natural habitats.69 
2. Azaphilones produced by endophytic fungus 
Colletotrichum sp. BS4 and their anti-bacterial potential 
2.1 Obtainment of azaphilones (10−14) 
Based on the pre-screened fermentation of strain Colletotrichum sp. BS4, it was 
fermented on rice medium and the biomass was extracted by EtOAc. By successive 
chromatographic and extensive spectroscopic methods as well as X-ray diffraction, four 
new compounds were isolated and identified, namely colletotrichones A−D (10−13), 
along with one known compound chermesinone B (14a)270 (Figure 17) (The detailed 
isolation procedure, see Chapter 4, 7.1).231 
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Figure 17. Structures of compounds 10−14 
2.2 The structural elucidation of compound 10 
Compound 10 was a colorless amorphous powder with the formula C18H20O7 
determined by ESI-HRMS, which showed 9 double bond equivalents (DBEs).231 In the 
1H NMR spectrum, four methyl groups, δH 0.69 (3H, t, J = 7.5, Me-14), 2.09 (3H, s, Me-
15), 1.65 (3H, s, Me-16) and 1.15 (3H, d, J = 7.0, Me-17), two olefinic protons δH 5.82 
(2H, s, H-3 and H-4), one acetal proton, δH 5.90, (1H, s, H-1) (identified by HSQC), and 
three further alkyl protons at δH 3.39 (1H, m, H-12), and 1.41 (2H, m, CH2-13) were 
observed (Table 3), which suggested two active protons exchanged by deuterium of 
NMR solvent.231 The signals of four methyl carbons, four downfield sp3 oxygen 
connected carbons, eight sp2 carbons including two carbonyl groups, one sp3 methylene, 
and one sp3 methine carbon were observed in the 13C NMR (Table 4) and HSQC 
experiments.231 1H, 1H COSY showed a spin-spin coupling system comprising Me-14 / 
CH2-13 / CH-12 / Me-17 (Figure 18).
231 The key heteronuclear correlations between 
carbons and protons (J2,3) in HMBC confirmed a dimethyl isochromene structure and a 
sec-butyl group (Figure 18).231 Since the 5 double bonds and two identified rings 
contribute only 7 DBEs, the remaining 2 DBEs were assigned to two further rings, as no 
additional sp2 signals were visible.231 However, the information above was not sufficient 
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to connect these moieties, because of the lack of protons at positions 6 to 11 for 2D 
NMR interpretations.231 To determine the correct structure of compound 10, a single 
crystal from ethyl acetate and methanol (1 : 1) was subjected to X-ray crystallography to 
analyze the structure (Figure 18).231 The crystal structure showed an isochromene group 
cis-fused with a furan ring and a pyran ring, which formed a unique stereo structure with 
a rigid and nearly rectangular bent core skeleton.231  
  
Figure 18. 1H, 1H COSY, key HMBC correlations and X-ray diffraction crystal structure 
(ORTEP drawing) of colletotrichone A (10)231 
Table 3. 1H NMR Spectroscopic Data of 10−12 at 500 MHz231 
Position 10a 11ab 12b 
1 5.90, 1H, s 7.30, 1H, s 3.95, 1H, dd (11.5, 5.4) 
3.84, 1H, dd (13.5, 11.5) 
3 5.82, 1H, s 6.00, 1H, s 5.48, 1H, br s 
4 5.82, 1H, s 5.36, 1H, br s 5.62, 1H, br s 
7 - 3.89, 1H, br s 3.10, 1H, dd (12.5, 11.5) 
8 - - 2.74, 1H,  
dddd (13.5, 11.5, 5.4, 1.5) 
10 - 3.89, 1H, br s 3.93, 1H, d (12.5) 
12 3.39, 1H, m 3.10, 1H, m 3.07, 1H, m 
13 1.41, 2H, m 1.60, 1H, m 
1.37, 1H, m 
1.79, 1H, m 
1.42, 1H, m 
14 0.69, 3H, t (7.5) 0.81, 3H, t (7.4) 0.90, 3H, t (7.5) 
15 2.09, 3H, s 2.14, 3H, s 1.95, 3H, s 
16 1.65, 3H, s 1.57, 3H, s 1.50, 3H, s 
17 1.15, 3H, d (7.0) 1.09, 3H, d (6.5) 1.19, 3H, d (7.2) 
a Measured in CD3OD, 
 b measured in CDCl3 
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Table 4. 13C NMR Spectroscopic Data of 10−12 at 125 MHz231 
Position 10a 11ab 12b 
1 97.2 147.2 69.0 
2 159.5 159.4 163.9c  
3 101.2 107.3 101.1 
4 118.9 105.8c 115.0 
5 194.9 191.5 192.5 
6 85.8 83.2c 83.4 
7 73.7 43.0 44.5 
8 63.4 114.6 35.6 
9 149.2 144.5 153.0  
10 103.2 55.7 52.6 
11 168.2 206.3 206.2 
12 35.1 46.6 47.8 
13 27.0 26.2 24.5 
14 11.0 11.1 11.5 
15 19.4 19.5 20.6 
16 17.1 23.2 18.8 
17 17.0 14.1 16.7 
18 168.4 168.6 168.8c 
a Measured in CD3OD, 
b measured 
in CDCl3, 
c assigned by HMBC 
As the relative configuration was unequivocally defined by X-ray diffraction, the absolute 
configuration must be identical with that depicted in the structure of 10, or with the mirror 
image thereof.231 The determination was made by calculation of the ECD and ORD data 
and by comparison of these data with the experimental values. Molecular mechanics 
calculations (SPARTAN'14, MMFF236) for 10 in a systematic approach resulted in the 
lowest energy 18 conformers in an energy range of 45 kJ/mol above the global 
minimum.231 By ab initio calculations using SPARTAN'14236 and Gaussian g09237 [finally 
with the wB97X-D functional and the 6-311++G(2df,2p) basis set], 11 conformers within 
a range of 16 kJ/mol (Gibbs free energy) above the global minimum were selected for 
further DFT calculations of the ECD and ORD data as described previously.78,231 As all 
conformers had positive OR values, the optical rotation Boltzmann-weighted from all 
conformers was positive (calcd. molar rotation = +396°/specific rotation +11.4°), and an 
experimental value of 340.4° was found for 10.231 As the enantiomer ent-10 would give a 
negative optical rotation and a mirror-imaged ECD spectrum with respect to Figure 19, 
the high similarity of experimental and calculated ECD and OR data unambiguously 
confirmed the absolute (1S,6R,7S,8S,12S)-configuration of 10, as depicted in the 
structure.231  
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Figure 19. Experimental (continuous line) and calculated (dashed curve) ECD spectra 
(in MeOH) of colletotrichone A (10)231 
2.3 The structural elucidation of compound 11 
 
Figure 20. 1H, 1H COSY, key HMBC and NOESY correlations of colletotrichone B (11a); 
3D structure is the conformer with the lowest energy231 
Compound 11a was isolated as yellowish oil with the formula C18H20O5, determined by 
ESI-HRMS.231 The 1H NMR, 13C NMR and HSQC data of 11a indicated the same 
pattern of sp2 and sp3 carbons as the known compound 14a isolated here as well, while 
the signals of CH-1, CH-10, Me-16 and Me-17 were quite different.231 HMBC and 1H, 1H 
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COSY experiments (Figure 20) revealed the same planar structure as for 14a and 
14b.231 In 2D NOESY experiments (in acetone-d6, see Chapter 8, Figure S30), nuclear 
Overhauser effects (NOE) were clearly observed between Me-16 and H-7 (H-7 and H-10 
have different chemical shifts in acetone-d6, Table 5), which indicated that the lactone 
ring is cis fused (Figure 20).231 Although there was a NOE cross peak between H-7 and 
H-10, it didn’t determine that H-7 and H-10 are on the same side of lactone ring, 
because even though they are on the different sides of the ring, the distance between 
them is still close enough to show NOE.231 For example, the NOE correlation between 
H-7 and H-10 appeared also in the NOESY spectrum of chermesinone B (in which H-7 
and H-10 have different orientations).231,270 Moreover, no unambiguous NOE was 
observed between H-10 and Me-16 even in 1D NOESY experiment with sufficient scan 
times (Chapter 8, Figure S31).231 Therefore, the configuration of H-10 related to Me-16 
and H-7 was not certain in the interpretation of NOESY experiments.231 For the relative 
configuration of H-12/Me-17, the NOE correlation was only observed between H-10 and 
H-12.231 
Table 5. 13C NMR (125 MHz) and 1H NMR (500 MHz) data of compound 11a in 
acetone-d6
231 
Position 11a (acetone-d6) 
δC δH mult. (J in Hz) 
1 146.9 7.38, 1H, s 
2 159.1  
3 106.8 6.25, 1H, s 
4 105.3 5.28, 1H, br s 
5 190.6  
6 82.7  
7 43.4 3.93, 1H, d (12.0) 
8 114.5  
9 144.0  
10 55.6 4.36, 1H, d (12.0) 
11 206.5  
12 46.7 3.05, 1H, m 
13 25.4 1.67, 1H, m 
1.36, 1H, m 
14 10.5 0.83, 3H, t (7.4) 
15 18.3 2.17, 3H, s 
16 22.4 1.51, 3H, s 
17 13.5 1.07, 3H, d (6.7) 
18 169.5  
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Table 6. Boltzmann averaged distances from H-10 to Me-17 and from H-10 to H-12 of 
four diastereomers of compound 11a (6R,7R,10R,12R (11c); 6R,7R,10R,12S (11a);  
6R,7R,10S,12S (11d); 6R,7R,10S,12R (11b))a, calculated on wB97XD/6-311+G(2df,2p) 
level of theory231 
6R,7R,10R,12R   Distance (Å) 
Conformer ∆G (Hartree) B-Factor H-10 to Me-17 H-10 to H-12 
1 0.00145 0.060484 2.505 2.585 
2 0 0.278278 2.417 2.605 
3 0.002852 0.01581 2.343 3.342 
6 5.9E-05 0.261522 2.824 2.514 
8 0.002454 0.024037 2.335 3.334 
10 0.001427 0.061966 2.5 2.589 
15 3.8E-05 0.267367 2.757 2.515 
20 0.00142 0.062425 2.497 2.588 
 Weighted average 2.620 2.58372903 
     
6R,7R,10R,12S   Distance (Å) 
Conformer ∆G (Hartree) B-Factor H-10 to Me-17 H-10 to H-12 
1 0 0.325127 4.258 2.462 
2 0.001332 0.080012 4.516 3.006 
3 0.002346 0.027519 4.482 2.585 
4 0.002216 0.031554 4.099 2.634 
6 0.00235 0.027403 4.483 2.589 
13 0.000114 0.288364 4.254 2.462 
17 0.000373 0.219555 4.255 2.464 
 Weighted average 4.284 2.518 
     
6R,7R,10S,12S   Distance (Å) 
Conformer ∆G (Hartree) B-Factor H-10 to Me-17 H-10 to H-12 
1 0.003284 0.014895 2.887 2.559 
3 0.003339 0.014058 4.258 2.358 
9 0.001525 0.094874 3.025 3.604 
10 0 0.472355 3.473 3.636 
12 0.002321 0.041046 3.379 3.617 
13 0.000312 0.340129 3.467 3.640 
 Weighted average 3.426 3.599 
     
6R,7R,10S,12R   Distance (Å) 
Conformer ∆G (Hartree) B-Factor H-10 to Me-17 H-10 to H-12 
1 0.002892 0.04132 2.454 2.348 
2 0.003739 0.016942 4.37 2.363 
3 0.003056 0.034769 4.087 2.35 
4 0.004156 0.010923 2.593 2.429 
9 0 0.86733 4.831 3.633 
10 0.003904 0.014241 4.775 3.462 
 Weighted average 4.711 3.525 
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The H-10 / H-12 and H-10 / Me-17 distances of optimized preferential conformers 
(Boltzmann factor > 0.01; Table 6) were calculated to figure out the possible 
configurations.231 In Table 6, I presumed that the configuration of C-6 is R, and the 
discussion showed below is useful for the assignment of relative configurations at 
position C-10 and C-12 of compound 11a.231  
For a flexible structure, the distance of each contributing conformer will result in dynamic 
averaged NOEs, if the interconversion between conformers is rapid enough on the NMR 
time-scale.231,271,272 Therefore, I can use Boltzmann averaged distance to describe the 
spatial relationship of atoms in compound 11a for NOESY analysis.231  
The relationship of interproton distance (rIS) and normalized NOE intensity (ƞIS) can be 
described by formulae:231,271,272 
  
When the NOESY measurement was performed within one experiment, the k and τm 
value can be considered to be constant for each spin pair.231,271,272  
Thus far, the distance and NOE intensity can be described in a proportional relationship 
showed below:231,271,272 
 
Therefore, I can conclude which pair of protons has closer distance by comparing the 
NOE intensities.231 
From the 2D NOESY spectrum, I can clearly see that there is a cross peak between H-
10 and H-12, while no cross peak is observed between H-10 and Me-17, which suggests 
that the averaged distance of H-10 and H-12 is smaller than H-10 and Me-17.231 
Moreover, the absence of cross peak between H-10 and Me-17 indicates the distance 
between them is larger than the detection limit.231 
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For 6R,7R,10R,12R (11c) configuration, the distance from Me-17 to H-10 and the 
distance from H-10 to H-12 are similar (the difference is only 0.036 Å), and are both 
smaller than 3 Å, where the NOE can be detected.231,273 For 6R,7R,10S,12S (11d) 
configuration, however, the distances between H-10 and Me-17 is smaller than H-10 and 
H-12.231  
It is worth to mention here that the earlier reported compound chermesinone C has 
7S,10S,12S configuration (which is also the same relative configuration to 7R,10R,12R), 
and its H-10 and Me-17 as well as H-10 and H-12 have cross peaks in NOESY 
spectrum.231,270 
Therefore, the two possibilities for compound 11a are 6R,7R,10R,12S and 
6R,7R,10S,12R (less likely) (or their enantiomers).231  
To distinguish between both diastereomers, I compared ab initio-calculated and 
experimental NMR data. Huang et al.231,270 solved the relative configuration of H-12/Me-
17 in the same way for two further diastereomers of 11a, namely the trans-lactones 
chermesinone B (14a) and monochaetin (14b).231,270,274 In accordance with the 
comparison of experimental NMR data and calculations (see Chapter 8, Tables S41 and 
S42), the chemical shift of Me-17 (δC17 = 14.1, δH17 = 1.09; calcd. 15.4 (err. 1.06) for 
(6R,6R,10R,12S)-11a) suggested that H-10 and Me-17 have the same relative 
orientation as in monochaetin (14b) (Me-17, δC17 = 14.4, δH17 = 1.11).
231,246 For all other 
(6R,7R,10ξ,12ξ) diastereomers 11c, d, higher shifts were calculated (see Chapter 8, 
Table S1), as exemplified experimentally for chermesinone B (14a: Me-17, δC17 = 17.1, 
δH17 = 1.24).
231,270 
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Figure 21. Experimental CD data in MeOH (black continuous line) and calculated ECD 
spectra of colletotrichone B (11a; red, dashed curve) and 10S,12R-epi-colletotrichone B 
(11b; blue dashed curve)231 
To further differentiate between the structures 11a and 11b, ab initio ECD calculations 
were performed.231 The calculated ECD curve of 11a showed the Cotton effect coincided 
with the experimental ECD spectrum (Figure 21).231 In contrast to this, the major 
negative Cotton effect at 290 nm in the calculated ECD value of 11b could not be 
explained by the experimental data.231 Therefore, the structure of colletotrichone B was 
determined to be 11a, and the absolute configuration was consequently determined to 
be 6R,7R,10R,12S.231 Notably, the assignment of the 6R,12S configuration could also 
be explained in view of its proposed biosynthetic pathway.231  
2.4 The structural elucidation of compound 12 
Colletotrichone C (12) was obtained as a colorless amorphous powder showing a 
pseudomolecular [M+H]+ ion, according to the formula C18H22O5.
231 In comparison with 
11a and 14a, the 1H NMR data (Table 3) of 12 displayed three further peaks at δH 2.74, 
3.95 and 3.84, and the absence of the sp2 CH signal of H-1 in compounds 11a (δH 7.30) 
as well as 14a (δH 6.83).
231 13C NMR (Table 4), HMBC and 1H, 1H COSY data (Figure 22) 
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suggested that the pyran ring was hydrogenated at positions 1 and 8.231 The coupling 
constants of H-7 (δH 3.10, 1H, dd, 12.5, 11.5), H-8 (δH 2.74, 1H, dddd, 13.5, 11.5, 5.4, 
1.5) and H-10 (δH 3.93, 1H, d, 12.5) indicated that these three methine protons are at 
axial positions, which was further confirmed by NOESY experiments (Figure 22).231 To 
determine the absolute configuration, ECD spectra were calculated by the method 
described above.231 The experimental spectrum was in agreement with the expected 
(6R,7R,8S,10S)-configuration of 12 (Figure 23).231 The configuration of C-12 was 
assigned as (S), based on the Me-17 shift (δC 16.7, δH 1.19) of 12, in comparison with 
the NMR data of compounds 11a and 14a.231 
 
Figure 22. 1H, 1H COSY, key HMBC and NOESY correlation of colletotrichone C (12)231 
 
Figure 23. Experimental (continuous line) and calculated (dashed curve) ECD spectra 
(in MeOH) of colletotrichone C (12)231 
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2.5 The structural elucidation of compound 13 
Compound 13 was isolated as a colorless amorphous powder, whose formula was 
determined by ESI-HRMS to be C19H22O7. Its 
1H NMR spectrum (Table 7) showed 
similar signals like compound 14, such as δ 7.38 (1H, s, H-1), 6.01 (1H, s, H-3) and 5.30 
(1H, br s, H-4), and four methyl peaks δ 2.17 (3H, s, Me-15), 1.49 (3H, s, Me-16), 1.18 
(3H, d, 6.9, Me-17) and δ 0.94 (3H, t, 6.8, Me-14), but it had one more methyl group at δ 
3.09 (3H, s, OMe-7), and a deuterium hydrogen exchangeable signal at δ 11.64 (1H, br 
s, OH-11). In 13C NMR spectrum (Table 7), compound 13 showed only one ketone 
carbonyl at δ 190.6 (C-5), eight other sp2 carbons at δ 146.2, 158.9, 105.8, 107.7, 114.2, 
142.0, 116.4 and 170.0, and two down field sp3 carbons connected with oxygen at δ 
83.4 and 96.5. In HMBC experiment (Table 7), key correlations were observed, including 
Me-15 (δ 2.17, 3H, s) between C-2 (δ 158.9) and C-3 (δ 107.7); Me-16 (δ 1.49, 3H, s) 
between C-5 (δ 190.6), C-6 (δ 83.4) and C-7 (δ 96.5); Me-17 (δ 1.18, 3H, d, 6.9) 
between C-11 (δ 170.0) and C-12 (δ 35.2); 11-OH (δ 11.64, 1H, br s) between C-10 (δ 
116.4) and C-12 (δ 35.2); and OMe-7 (δ 3.09, 3H, s) between C-7 (δ 96.5). By 1H, 1H-
COSY technology, moreover, the fragment of sec-butyl side chain was clearly confirmed. 
After assigning all these proton and carbon signals, there were two sp3 quaternary 
carbons connected with oxygen, namely C-6 (δ 83.4) and C-7 (δ 96.5), while there were 
three unassigned oxygen atoms according to the formula C19H22O7. The C-7 (δ 96.5) 
with significant deshielding effect suggested the bond between C-17 and the methyl 
group (δ 3.09, 3H, s) is a ketal group connected with OMe-7 and another oxygen atom 
between C-7 and C-11. In 1D NOESY, OMe-7 and Me-16 showed no correlation, which 
suggested the OMe-7 group and Me-16 are on the different sides.  
Table 7. 1H NMR (500 MHz) and 13C NMR (125 MHz) spectroscopic data for compound 
13 at 500 MHz 
Position 1H NMR (J in Hz) 13C NMR HMBC 
1 7.38, 1H, s 146.2 C-2, C-8, C-9 
2  158.9  
3 6.01, 1H, s 107.7 C-2, C-4, C-8 
4 5.30, 1H, br s 105.8 C-3, C-6, C-8 
5  190.6  
6  83.4  
7  96.5  
8  114.2  
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9  142.0  
10  116.4  
11  170.0  
12 2.88, 1H, m 35.2  
13 1.69, 1H, m 
1.59, 1H, m 
27.6 C-12, C-14, C-11, C-17 
14 0.94, 3H, t (6.8) 12.5 C-12, C-13 
15 2.17, 3H, s 19.9 C-2, C-3 
16 1.49, 3H, s 21.9 C-5, C-6, C-7 
17 1.18, 3H, d (6.9) 17.6 C-11, C-12,C-13 
18  165.2  
11-OH 11.64, 1H, br s  C-10, C-11, C-12 
7-OMe 3.09, 3H, s 50.3 C-7 
a Assigned by HSQC because of overlapping 
 
 
Figure 24. Two possible structures of compound 13 
 
Figure 25. Experimental (continuous line) and calculated (dashed curve) ECD spectra 
(in MeOH) of colletotrichone C (13) 
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Table 8. Calculated 13C NMR of structure 13a and 13b 
Position Exp. 13C NMR 13a Abs. error 13b Abs. error 
1 146.2 148.6 2.4 148.0 1.8 
2 158.9 161.1 2.2 160.2 1.3 
3 107.7 109.7 2.0 110.0 2.3 
4 105.8 106.6 0.8 108.4 2.6 
5 190.6 187.9 2.7 191.7 1.1 
6 83.4 81.5 1.9 86.6 3.2 
7 96.5 94.6 1.9 89.3 7.2 
8 114.2 116.1 1.9 118.8 4.6 
9 142.0 142.6 0.6 145.4 3.4 
10 116.4 117.5 1.1 97.0 19.4 
11 170.0 171.4 1.4 186.1 16.1 
12 35.2 36.1 0.9 41.4 6.2 
13 27.6 29.4 1.8 27.0 0.6 
14 12.5 13.3 0.8 13.4 0.9 
15 19.9 19.8 0.1 19.2 0.7 
16 21.9 22.1 0.2 27.2 5.3 
17 17.6 18.6 1.0 20.5 2.9 
18 165.2 164.6 0.6 175.1 9.9 
OMe 50.3 47.7 2.6 60.9 10.6 
  MAE 1.4 MAE 5.3 
*MAE is an abbreviation of mean absolute error 
However, there is another possibility that C-7 and C-11 have a direct bonding and C-7 is 
connected to a methyl group by a peroxide bond (Figure 24). Therefore, GIAO DFT 13C 
NMR calculations of these two structures were performed (Table 8). The calculated data 
of proposed structure 13a showed high agreement with the experimental 13C NMR, 
which revealed that the correct structure is 13a as proposed.  
The absolute configuration of 13a was determined by ECD calculation similar to the 
methods described for compounds (10−12) (by different software and level of theory, 
see Chapter 4, section 8). The Boltzmann averaged calculated ECD curve of structure 
13a matched the experimental data well (Figure 25). Therefore, the absolute 
configuration of compound 13a was assigned to be 6S,7S,12S.  
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2.6 Proposal of biosynthetic pathway of azaphilones (10−14) 
 
Figure 26. Proposed biosynthetic pathway of compounds 10−14231 
The compounds 10−14 are typical polyketides, whose biosyntheses have been 
comprehensively investigated in numerous studies.231,164 Interestingly, for the sec-butyl 
substructure, a condensation product originating from two different polyketides, but not 
from a single octaketide chain was proposed.164,231,274 With respect to their structures, 
the biosynthesis of compounds 10−14 might proceed from a pentaketide via an 
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isochromene analogue, which is first acylated and then condensed with a 4-methyl-3-
oxohexanioc acid or 4-methyl-2-OH-3-oxohexanioc acid, and further modified by 
oxidation or hydrogenation, according to the proposed biosynthesis of other azaphilones 
(Figure 26).164,231,275 Borges et al. proposed a pathway of cyclization of chaetoviridin I, 
whose essential steps were an epoxidation at double bond ∆7 and subsequent 
hydrolysis.231,276 Considering the SN2 mechanism or steric effects, however, the 
hydrolysis at the epoxy group is more likely to generate two trans-hydroxy groups.231 
Therefore, I proposed an aforementioned biosynthetic pathway to explain the formation 
of the ring system and configurations of compound 10 and 13 (Figure 26).231 
2.7 Antibacterial assay of compounds (10−14) and cytotoxic assay of compounds 
(10−12, and 14a) 
It is well-known that azaphilones have a broad range of biological activities including 
antimicrobial, cytotoxic, anticancer, antiviral and anti-inflammatory properties.164,231 In an 
earlier investigation on azaphilones from stromata of Xylariaceae, Hellwig et al. 
suggested that they are maintained in the course of their co-evolution with angiosperm 
hosts and involved in a kind of chemical defense reaction to keep the fitness of their 
producers.231,277 Moreover, some azaphilones with similar lactone substructures were 
reported to have antibacterial activities. For instance, deflectin B-2a showed a minimum 
inhibitory concentration (MIC) of 5 µg/mL against Bacillus. brevis and B. subtilis ATCC 
6633 on a complex medium.231,278 Moreover, sassafrins A−C showed moderate 
antibacterial activities against Staphylococcus aureus, Pseudomonas aeruginosa, 
Klebsiella pneumonia, and Escherichia coli. In another study, multiformins A−D were 
shown to have moderate to strong activity against S. aureus, P. aeruginosa, K. 
pneumonia, E. coli and Salmonella enteritidis.231,279  
Therefore, given the potent antibacterial efficacies of azaphilones, we evaluated the 
antibacterial effectiveness of our isolated compounds against two widely distributed 
environmental strains of E. coli (Gram-negative) and B. subtilis (Gram-positive), as well 
as against two human pathogenic bacterial strains of S. aureus (Gram-positive) and P. 
aeruginosa (Gram-negative).78,231 Compound 10 showed pronounced efficacies 
particularly against both the tested environmental strains comparable to the standard 
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antibiotics (Table 9).231 Additionally, compound 12 was quite active against the 
environmental strain of E. coli.231 Furthermore, compound 11a exhibited the same 
efficacy as streptomycin against clinically relevant, risk-group 2 (RG2) bacterium S. 
aureus.231 Since the endophytic fungus was isolated from the leaves of B. sinica, it is 
compelling that it provides some form of azaphilone-mediated chemical defense to the 
host plant against invading specialist and generalist bacteria.231 In order to discern the 
antibacterial selectivity of the compounds, their cytotoxicity against human acute 
monocytic leukemia cells (THP-1) was evaluated not only using a resazurin-based assay 
to measure the THP-1 mitochondrial metabolic inhibition but also an ATPlite assay to 
measure the THP-1 cytoplasmic ATP depletion.231  
Table 9. Minimum inhibitory concentrations (MIC) of the compounds 10−14 against 
Gram-positive and Gram-negative bacteria compared to standard references231 
(streptomycin and gentamicin)a 
Organism (DSMZ no.) 10 11a 12 13 14a streptomycin gentamicin 
Staphylococcus aureus (DSM 
799) 
>10 5.0 >10 >10 >10 5.0 1.0 
Escherichia coli (DSM 1116) 1.0 >10 5.0 >10 >10 1.0 1.0 
Bacillus subtilis (DSM 1088) 0.1 >10 >10 >10 >10 5.0 1.0 
Pseudomonas aeruginosa (DSM 
22644) 
>10 >10 >10 >10 >10 10.0 1.0 
aAll values are in μg/mL and derived from experiments in triplicate. 
None of the tested compounds (10, 11a, 12 and 14a) demonstrated potential cytotoxic 
effects against THP-1 cells at low concentrations (Figure 27) while they inhibited the 
growth of tested microorganisms in the antibacterial assay (Table 9). Although 
compounds 12 and 14a showed moderate cytotoxic efficacies at higher concentrations 
(≥ 10 M), these could be considered potentially insignificant.231 
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Figure 27. In vitro cytotoxic assays of compounds 10, 11a, 12 and 14a against THP-1 
cells using a resazurin-based assay (to measure metabolic activity) as well as an 
ATPlite assay (to measure ATP content). Semilogarithmic representation of the 
fractional survival (FS in %) of THP-1 cells as a function of concentration is provided231 
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2.8 Visualization of azaphilones in the colony of Colletotrichum sp. BS4 by MALDI IMS  
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Figure 28. Spatial distribution of compound 10 and compound 11a/14a produced by 
endophytic Colletotrichum sp. BS4 on rice agar after 16 days. a Optical image of colony 
and the cross section of agar layer on glass slide. b Detected area for MALDI IMS. c 
Spatial distribution of compound 10 ([M+K]+, m/z 387.0841). d Spatial distribution of 
compound 11a and/or 14a ([M+K]+, m/z 355.0942)67 
Matrix-assisted laser desorption ionization imaging high-resolution mass spectrometry 
(MALDI-imaging-HRMS) experiments were performed to visualize the endophytic 
production and spatial distribution of compounds 10−14 over 16 days in an attempt to 
understand the plausible ecological relevance (Figure 28).67 Colletotrichum sp. BS4 
revealed some typical morphological features of the genus110,280,281 such as the dark-
colored, thick-walled hyphal clumps (setae) (Figure 28a), which was the primary site of 
production of compound 10 as well as compound 11a and/or 14a within only a few days 
of culturing on rice agar.67 However, it was interesting to note that compound 10 was 
secreted into agar after production, while compound 11a/14a was localized at the site of 
production at or around the hyphal clumps (Figure 28c, d).67 From the ecological point of 
view, some interesting connotations could be made.67 Plant-associated Colletotrichum 
species are known to utilize setae (or associated appressoria) for attachment to host 
surface for penetration into the host tissue.67,281 Concomitantly, it was noteworthy that 
the bioactive compound 10 diffused away from the site of production (hyphal clump) by 
the endophyte while retaining the less active compound 11a/14a (Table 9) at the hyphal 
clumps where they were produced.67 It might be plausible that compound 10 is removed 
from the site of production by the endophyte, which is also the possible site of its 
association with the host plant, in order to avoid activation of the plant immune signals 
and/or to prevent it from interfering with the endophyte-mediated ecological balance in 
plant tissues.67,282 This is further coincident with its proposed biosynthetic pathway 
(Figure 26) that 14a is the lesser-active precursor of the potent bioactive compound 10. 
2.9 Discussion 
Endophytic fungi are considered as a rich source of functional metabolites, owing to their 
specialized niches.34,35 Given that endophytic fungi can increase the ecological 
adaptability of host plants,34,35 these endophytic fungi are supposed to be relevant to the 
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tolerance of B. sinica towards biotic or abiotic stresses. B. sinica is widely used as 
boxwood and cut into different shapes. These anti-bacterial azaphilones may help the 
host plant to defend against the pathogens invading from wounds, which has proven 
that we can discover new bioactive compounds based on proposed ecological functions 
of endophytes. Most importantly, since the most active compound 10 showed 
insignificant cytotoxicity towards a human cell line, it has the potential to be an anti-
bacterial lead compound to develop new antibiotics in further investigation.  
3. Lactam-fused 4-pyrones producing endosymbiotic 
community comprising of endophytic fungus P. capitalensis 
BS5 and its endosymbiotic bacterium Herbaspirillum sp. 
BS5B 
3.1 Identification of fungus P. capitalensis BS5 and endosymbiotic bacterium 
Herbaspirillum sp. BS5B 
In the research of endophytes harbored in traditional Chinese medicinal plant Buxus 
sinica, endophytic fungus BS5 was isolated from healthy leaves on water agar. This 
fungus was identified and characterized to be Phyllosticta capitalensis BS5 (teleomorph 
Guignardia mangiferae) harboring an endosymbiotic bacterium Herbaspirillum sp. BS5B, 
based on ITS and 16S rRNA analysis of the total genomic DNA of fungal culture 
following previously established methods.54,130,252 Briefly, the sequences were matched 
against the nucleotide database of the US National Centre for Biotechnology Information 
(NCBI) using the Basic Local Alignment Search Tool (BLASTn) and aligned using the 
EMBOSS-Pairwise Sequence Alignment of the EMBL Nucleotide Database.130 The ITS 
and 16S rRNA sequences have been deposited at the EMBL Bank (accession numbers 
LN828209 and LN864763, respectively).130 The presence of endosymbiotic bacterium 
Herbaspirillum sp. BS5B within fungal mycelia was confirmed by the amplification of 
highly conserved 16S rRNA region283 using fungal DNA as template.130 As a negative 
control template DNA was replaced with sterile double distilled water.130 Amplification of 
1500 bp (base pairs) fragment in endophytic fungal isolate BS5 and its absence in 
negative control confirmed the presence of endosymbiotic bacterium within fungal 
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mycelia (Figure 29).130 In this case, however, free living endosymbiotic bacterium is not 
yet isolated in the laboratory conditions. Moreover, it was observed that the amplification 
of 16S rRNA from the fungal metagenome was related to the subculture generation of 
fungus.130 The positive band was amplified only when PCR analysis was performed 
using template DNA of first generation fungal isolate (mother plate).130 Repeated 
subculturing resulted in loss of the desired fragment (data nor shown), which pointed 
towards the loss of endosymbiotic bacterium, when culturing the fungus under in vitro 
conditions different to that of its ecological niche.130 
 
Figure 29. Stained agarose gels of purified PCR products of ITS and 16S rRNA 
sequences of total genomic DNA of endophytic fungal isolate BS5 harbored in Buxus 
sinica. An approximately 600 bp (sample 2) and 1500 bp (sample 3) band obtained for 
fungal isolate BS5 and its bacterial endosymbiont 
3.2 Structural elucidation of compounds 15 and 16 
As the OSMAC (One Strain Many Compounds) approach255 utilized in our former 
investigation on endophytes,69,78 different media and conditions were screened for the 
fermentation of this fungus. In static PDB, two new compounds phyllostictalactam A and 
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B (15 and 16) (Figure 30) was detected in the ethyl acetate (EtOAc) extracts of both 
mycelia and broth by LC-HRMS.130  
 
Figure 30. The structures of compound 15 and 16 
Compound 15 was purified as a colorless powder from by C18 column on semi-
preparative HPLC from large scale fermentation media.130 The formula C13H15O5N of 
compound 15 was determined by ESI-HRMS.130 The 1H NMR spectrum showed a 
typical n-propyl group consisting of δH 2.07 (2H, dt, J = 7.4, 6.0 Hz), 1.57 (2H, dq, J = 
7.4, 7.4 Hz) and 0.99 (3H, t, J = 7.4 Hz), two trans double bond protons δH 6.62 (1H, d, J 
= 16.0 Hz) and 6.66 (1H, d, J = 16.0, 6.0, Hz), one singlet of methyl group at δH 1.78 (3H, 
s) and one deuterium exchangeable proton at δH 7.76 (1H, br s) (Table 10).
130  
Table 10. 1H and experimental 13C NMR, and HMBC correlations of compound 15 
(acetone-d6)
130 
Position 1H NMR (J in Hz) Exp. 13C NMR HMBC correlations 
1 - 164.0  
2 - 110.5  
3 - 176.3  
4 - 82.9  
5 - 169.2  
6 - 142.5  
7 - 145.5  
8 1.78, 3H, s 23.3 C-3, C-4 
9 6.62, 1H, d, J = 16.0 118.0 C-7 
10 6.66, 1H, d, J = 16.0, 6.0 137.1 C-7, C-9, C-11, C-12 
11 2.07, 2H, dt, J = 7.4, 6.0 35.4 C-7, C-9, C-10, C-12, C-13 
12 1.57, 2H, dq, J = 7.4, 7.4 22.2 C-10, C-11, C-13 
13 0.99, 3H, t, J = 7.4 13.5 C-11, C-12 
HN 7.76, 1H, br s - C-1, C-2, C-3, C-4, C-5, 
 
The 13C NMR and HSQC spectra displayed thirteen carbons including two methyl 
groups, two methylene groups, two olefinic methine groups and other seven quaternary 
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carbons (Table 10), suggesting two more deuterium exchangeable protons which were 
not observed in 1H NMR spectrum.130 In the HMBC experiment (Table 10), the lack of 
available protons around the core structure caused difficulties for determining the planar 
structure and only the side chain namely 1-pentene substructure can be confirmed by 
2D NMR.130 
Herein, the 1D and 2D NMR technologies can hardly resolve this structure elucidation of 
compound 15. Unfortunately, to date all efforts to culture the single crystal of compound 
15 proved futile, and consequently X-ray diffraction experiment was not feasible either. 
The chemical shifts of C-1, C-3 and C-5 showed they are carbonyl groups or β position 
of unsaturated ketone. Therefore, there are only dozens of structures possible and GIAO 
DFT 13C NMR calculation can be applied to verify those proposed structures. The GIAO 
shielding constants were calculated on mPW1PW91/6-31+G(d) level of theory,284 using 
MeOH and benzene as references for sp3 and sp2 hybridized carbons respectively.207 To 
increase the efficiency, the maximum gradient of geometry optimization for candidate 
structures was set to threshold 0.001 (default value is 0.0001) and only their global 
minimum conformers (calculated by semi-empirical PM3 method) were calculated. After 
the first screen, only the structure 15 as depicted in Figure 30 has maximum absolute 
deviation within 10 ppm. Then geometry optimization and frequency calculations were 
further performed for all the conformers of structure 15, and the calculated 13C NMR 
data of them were Boltzmann averaged according to Gibbs free energy (Table 11).130 
Owing to the energy barrier, some conformers are not able to interchange freely.130 The 
detected 13C NMR signals may not be the dynamically averaged value of all conformers 
in some cases, and the Boltzmann averaged data are not always better than the global 
minimum conformer.130,207 Therefore, the data of global minimum conformer and 
averaged data of different sets of conformers were all considered in order to confirm the 
proposed structure (Table 11).130 According to the reported standard and many applied 
cases,197,202–206 the MAE showed high agreement between experimental data and 
calculated data.130 Compared to the reported compound cordylactam, the 13C NMR data 
are similar except the significant difference at position 4 (cordylactam, δC 50.3; 
compound 15, δC 82.9) and Me-8 (cordylactam, δC 17.8; compound 15, δC 23.3).
173 Thus, 
the planar structure of compound 15 can be determined affirmatively. The optical 
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rotation and CD effect of compound 15 can be barely detected, which revealed it is a 
mixture of enantiomers.130  
Table 11. Experimental 13C NMR, calculated 13C NMR data of global minimum 
conformer (G. M.), and Boltzmann averaged data of s-trans, s-cis and all conformers 
Position Exp. 
data 
G. M. S-trans (64.48%) S-cis (35.52%) All conformers 
Data Error Data Error Data Error Data Error 
1 164.0 163.2 -0.8 163.3 -0.7 163.4 -0.6 163.3 -0.7 
2 110.5 110.8 0.3 110.8 0.3 110.2 -0.3 110.6 0.1 
3 176.3 177.3 1.0 177.3 1.0 177.0 0.7 177.2 0.9 
4 82.9 80.8 -2.1 80.8 -2.1 81.0 -1.9 80.9 -2.0 
5 169.2 165.9 -3.3 165.9 -3.3 165.5 -3.7 165.8 -3.4 
6 142.5 143.4 0.9 143.5 1.0 145.5 3.0 144.2 1.7 
7 145.5 145.8 0.3 145.9 0.4 146.8 1.3 146.2 0.7 
8 23.3 23.0 -0.3 23.0 -0.3 22.7 -0.6 22.9 -0.4 
9 118.0 119.5 1.5 119.2 1.2 122.7 4.7 120.5 2.5 
10 137.1 142.7 5.6 142.2 5.1 149.1 12.0 144.6 7.5 
11 35.4 36.0 0.6 36.0 0.6 37.0 1.6 36.4 1.0 
12 22.2 22.4 0.2 23.4 1.2 23.1 0.9 23.3 1.1 
13 13.5 12.6 -0.9 12.5 -1.0 12.3 -1.2 12.4 -1.1 
  MAE 1.4 MAE 1.4 MAE 2.5 MAE 1.8 
*MAE is an abbreviation of mean absolute error 
Compound 16 was detected by LC-ESI-HRMS with formula C13H13O4N determined, 
which has one less H2O than compound 15.
130 However, I failed to use conventional 
chromatographic methods to purify it, because of its poor stability and insufficient 
quantity during the process of purification.130 By the dehydration reaction of compound 
15 (Figure 31),285 I confirmed the product is exactly compound 16 with the same 
retention time and MS2 fragmentation in LC-MSn measurement (Chapter 8, Figure S56 
and S57).130 
 
Figure 31. Semi-synthesis of compound 16130 
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3.3 Biosynthetic pathway of compounds 15 and 16 
 
Figure 32. Stained agarose gels of purified PCR products of polyketide synthase 
genes (PKS; spanning around 700 bp) of endophytic isolate BS5 (harboring 
bacterial endosymbiont). An approximately 700 bp PKS band amplified for isolate 
BS5 using both bacterial and fungal PKS degenerate primers (sample 3 and 5), 
although both PKS bands encodes for fungal polyketide. Aspergillus versicolor 
(isolate A12)252 (sample 2) and Bacillus subtilis (DSM 1088) (sample 4) are the 
positive controls and sterile double distilled water is the negative control (sample 
6)130 
Similar compounds such as cordylactam,173 and pyranonigrin A, E, F, G, H, and 
S172,175–179 were isolated from Cordyceps sp. and Aspergillus niger.130 The isotope 
labeling experiment172 and gene mining179 showed the these compounds are 
biosynthesized via hybrid PKS/NRPS pathways.130 Considering the case that 
endosymbiotic Burkholderia bacteria was unveiled to be the hidden producers of 
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fungal phytotoxin,234,286,287 we evaluated the fungal and bacterial PKS and NRPS 
to assign the production of compounds 15 and 16.130 
 
Figure 33. Stained agarose gels of purified PCR products of nonribosomal 
peptide synthetase (NRPS; spanning around 300 bp for fungus and 1000 bp for 
bacterium) of endophytic isolate BS5 (harboring bacterial endosymbiont). No 
NRPS band present in fungal isolate BS5 (sample 5), but an approximately 1000 
bp NRPS band amplified for bacterial endosymbiont of isolate BS5 (sample 4). 
Aspergillus versicolor (isolate A12)252 (sample 2) and Bacillus subtilis (DSM 1088) 
(sample 3) are the positive controls and sterile double distilled water is the 
negative control (sample 6)130 
Production of secondary metabolites usually comprises of a combination of PKS 
and NRPS,253,288 that often forms PKS-NRPS hybrids determining the structure 
and biological activity of resulting natural products.130 For the identification of PKS, 
degenerate primers were designed based on genes encoding the highly 
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conserved KS domain of fungal and bacterial isolates as described in 
literature.130,249–251 As expected, the degenerate primers amplified the desired 700 
bp fragments in positive controls Bacillus subtilis and Aspergillus versicolor under 
optimized PCR cycling conditions.130 The amplified fragments were sequenced, 
translated into respective protein sequences and matched using UniProtKB 
showing homology to polyketide synthases (M4KVE6 and W5S7R8) of positive 
controls.130  
Thereafter, the template DNA of fungal endophyte harboring bacterial 
endosymbiont was subjected to PCR amplification with same degenerate 
primers.130 This resulted in amplification of 700 bp fragment with fungal and 
bacterial PKS primers (Figure 32).130 The obtained positive sequences were 
purified, sequenced and matched using the Basic Local Alignment Search Tool 
(BLASTn) of NCBI.130 Even though both degenerate primers amplified the desired 
positive fragments, the amplified fragments showed 95% identity only with 
polyketide synthase gene of Guignardia sp. (JX144685.1) (teleomorph of genus 
Phyllosticta), which is a fungal polyketide synthase gene.130 The sequences were 
further translated to respective protein sequences using UniProtKB showing 76.6% 
identity with fungal polyketide synthase (V5FKW9).130 Thus this proved that the 
PKS originated from the endophytic fungus BS5 and not the endosymbiotic 
bacterium.130 
For the identification of NRPS, degenerate primers were designed based on 
genes encoding the conserved adenylation domain (A) of fungal and bacterial 
isolates as described in literature.130,251,253,254 As expected, the degenerate 
primers amplified the desired 1000 bp fragment in positive control Bacillus subtilis 
and 300 bp fragment in positive control Aspergillus versicolor under optimized 
PCR cycling conditions.130 The amplified fragments were sequenced, translated 
into respective protein sequences and matched using UniProtKB showing 
homology to nonribosomal peptides of positive controls.130 Henceforth, the 
template DNA of fungal endophyte harboring bacterial endosymbiont was 
subjected to PCR amplification with same degenerate primers.130 This resulted in 
amplification of 1000 bp fragment of bacterial NRPS (Figure 33).130 No 
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amplification of fungal NRPS was observed.130 The positive sequence thus 
obtained was purified and sequenced.130 Unfortunately, the fragment did not yield 
any sequencing results.130 On rechecking the purified fragment by agarose gel 
electrophoresis, it was found that the single band was separating into two bands; 
one at 1000 bp and another at 700 bp (fragment size similar to fungal PKS).130 On 
repeating the purification and separation steps, similar result was always obtained 
(Figure 34).130 It pointed towards the fact that there might be presence of PKS-
NRPS hybrid in endophytic fungus BS4 harboring the endosymbiotic bacterium 
which could not be separated from the fungal PKS by general PCR amplification 
methods using degenerate primers.130 
 
Figure 34. Stained agarose gels of separating the purified 1000 bp fragment of bacterial 
NRPS resulting in 1000 bp fragment and 700 bp fragment (similar to fungal PKS).130 
3.4 Discussion 
In the previous research, Kusari et al. demonstrated that the cross-species 
biosynthesis pathway of camptothecin consists of endophytic precursor 
biosynthesis and the final condensation of host plant,39,95,130 and also elaborated 
that endophytic bacteria harboured in the roots of Putterlickia verrucosa and P. 
retrospinosa are the producer(s) of maytansine.54,130 Furthermore, the 
investigation of the biosynthesis of rhizoxin showed that the bacterial 
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endosymbiont produced the basic scaffold and the host fungus involved in core 
structure tailoring.130,289 To our best knowledge, however, the cross-species 
collaboration of hybrid PK/NRP backbone biosynthesis is firstly reported in 
fungus-bacterium endosymbiotic system in this article (Figure 35).130 
 
Figure 35. Biosynthetic pathway of compounds 15 and 16130 
Endophytic communities consisting of host plants and endophytes are complex 
ecological systems. In previous reports, a number of “plant” natural products could be 
actually produced or partially biosynthesized by associated endophytes.18,130 The 
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endosymbiotic scenarios of endophytes, furthermore, lead to probably a higher level of 
complexity of endophytic interactions,18,130 which could be another challenge for the 
future investigation. These hidden endosymbiotic endophytes and their corresponding 
functions are likely essential parts of the whole interaction network of the endophytic 
system.130  
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1. Conclusion 
In this work, the discovery of these cryptic hexacyclopeptides showed that the standard 
procedure herein is robust and efficient to investigate secondary metabolites produced 
by endophytes including the compounds with only physiological concentration. The 
structures of hexacyclopeptides were elucidated by LC-MSn, with the information of their 
building blocks determined. Considering the D-amino acids could also be building blocks 
in cyclopeptides (because of the E domain of NRPS pathways), however, the relative 
configurations cannot be assigned. Although the α-deuterated amino acids of all building 
blocks were successfully obtained, it still did not work following the reported methods of 
absolute configuration assignment for cyclopeptides,261 because of the transaminase in 
the fungal cells. In the literature, they knocked out corresponding genes of 
transaminases in the host bacteriua.261 The same strategy could also be applied on the 
strain F. solani N06. Whereas, the corresponding genes in eukaryotes are different from 
prokaryotes, whose structures and functions should be investigated in future work. 
Herein, the deuterium labeling experiment is a very important method to determine 
whether the natural products are produced by this fungus. Moreover, by labeled Leu/Ile 
precursors and proline derivatives the planar structure of each compound (1−9) could 
also be determined. The bottleneck, however, is the lack of available fungal materials of 
this strain because of the degeneration of the production of these hexacyclopeptides, 
which hampered further labeling experiments. The visualization of the chemical crosstalk 
between the two endophytes unambiguously supported the hypothesis of signaling 
interactions among endophytic niches. This case also exemplified the idea of 
“distribution represents functions”, which could be developed as a routine method for 
future research of secondary metabolites from endophytes. However, beside the 
accumulation and degradation behavior of the neighbor bacterium, no in-depth function 
can be deciphered for now, which could be a blind spot of current methods. In the future, 
the investigation on the possible cascade pathway of this signaling system should be 
emphasized, because it could lead to the interpretation of many functions of the 
endophytic system in their host plants. 
From the endophytic Colletotrichum sp. BS4 harbored in the leaves of B. sinica, 
azaphilones were purified and elucidated by extensive spectroscopic methods, X-ray 
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diffraction as well as quantum chemical calculations. Notably, compound 10 exhibited 
even higher activities against E. coli and B. subtilis than selected antibiotics in the 
antibacterial assay. Considering they didn’t show significant cytotoxicity towards the 
human cancer cell line, they could have the potential to be developed as a group of 
antibiotics with different core structure from the known antibacterial drugs. This case 
also exemplified that promising microbial sources of natural products could be isolated 
from the niches with evolutionary traits corresponding to bioactivities. For the next 
research, in vivo experiments including bioassay on animal models are necessary for us 
to determine whether they can be applied as efficiently and safely as antibiotics.  
The endophytic fungus P. capitalensis BS5 was isolated from the leaves of B. sinica, 
with a cryptic endosymbiotic bacterium Herbaspirillum sp. BS5B detected by 16S rRNA 
analysis. This fungus produced lactam-fused 4-pyrones (15 and 16) in static PDB 
medium. To determine their producer(s), metagenome evaluation towards PKS and 
NRPS was performed, revealing the PKS gene was from this fungus while NRPS gene 
was from the endosymbiotic bacterium. However, the bacterial NRPS was not 
successfully sequenced. The further studies including full gene sequence of both 
microorganisms along these lines will be underway. To my best knowledge, this is the 
first report of cooperation of PKS/NRPS biosynthesis for endophytes. In the view of co-
evolution, these compounds are supposed to have one or more ecological functions 
regarding endosymbiotic relationship. So far, however, no bioactivity of these 
compounds was detected within current bioassay or co-culture experiments. The 
mutants of this fungus with defection of biosynthesis or the endosymbiont-free strain of 
this fungus could be important negative controls to unveil the true biofunctions of these 
compounds, which may be obtained in future research. 
2. Interspecies chemical crosstalks among endophytic 
communities 
The association of microbes with higher plants or animals is a common phenomenon in 
nature. Recently, Wada-Katsumata et al. demonstrated that the gut microbial community 
is responsible for the production of aggregation pheromones for the host German 
cockroach.67,290 Moreover, Santhanam et al. reported that root-associated bacterial 
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community of tobacco plants (Nicotiana attenuata) in their native habitat increased the 
resistance and survivability of host plant towards sudden tissue collapse and black roots 
significantly.67,291 The consortium of bacteria rather than any single member in the 
bacterial community provides protection for the host plant, which revealed that 
prokaryotes and plants have developed opportunistic mutualisms by co-evolution.67,291 It 
is widely accepted that, in most ecological niches comprising of multiple members 
including endophytic systems, organisms are not simply living together but maintaining 
complex relationships encompassing each member.67  
Co-evolving for millions of years, endophytes and plants have already developed many 
strategies to survive with the presence of each other and change their living status to 
adapt towards coexistence. For example, Lahrmann et al. reported how endophytic 
fungus Piriformospora indica evades the defense of host plants like Arabidopsis by 
establishing a biotrophic interaction.67,292 At the early stage of colonization, P. indica 
interferes with the plant hormone level and secretes fungal lectins and small proteins to 
suppress host defenses.67,292 Then, P. indica grows in moribund host cells and secretes 
hydrolytic enzymes to digest proteins.67,292 However, the invasion does not cause 
massive host cell death as other necrotrophic or hemibiotrophic fungi, but benefit the 
host plant by providing it tolerance to biotic and abiotic adversities.67,292 Moreover, the 
colonization of endophytes can also influence the gene expression of both endophytic 
fungi and host plants. Bailey et al. reported that when bio-control endophytic 
Trichoderma species colonize into host plant (Theobroma cacao), a number of genes of 
both fungal and plant are induced or repressed.67,293 The switch-on/off of genes reveals 
that fungal endophytes and their hosts have established a genetic crosstalk system 
during the endophytic association.67,293 Therefore, separating endophytic fungi from their 
habitat (host plant tissue) will probably alter their genotypic as well as phenotypic 
characteristics, including the biosynthetic genes responsible for producing certain 
secondary metabolites.67 Some metabolites or pathways are only necessary for 
microbes in the endophytic life cycles, and they will shut them down in the environments 
without association with plants.67 This may be the reason why F. solani N06 stopped 
producing these crosstalk molecules in laboratory conditions. 
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It is also worth to note that the crosstalk hexacyclopeptides are structurally different from 
previously reported microbial signal molecules, including acyl-homoserine lactones 
(AHLs), AI-2, CAI-1 related α-hydroxy ketones (AHKs), ComX pheromones, diffusible 
signal factors (DSFs), diffusible extracellular factor (DF), and Phytophthora mating 
hormones.80 There are many coexisting micro- and macro-organisms including cells of 
host plant, other endophytes as well as their endosynbiotic bacteria in the natural niches 
of endophytes. Because of unique adaptive traits and natural selection, endophytes may 
develop specialized signaling systems, which are independent on the ones of other 
microbies including invading pathogens. Kusari et al. reported that endophytic bacteria 
employ quorum quenching strategy to defend host plant against virulent microbes.246 
Given that these endophytic bacteria are not influenced by quorum quenching strategy, 
their quorum sensing systems are likely different from common ones including AHLs 
systems. Therefore, utilizing unique crosstalk molecules can provide endophytic system 
advantages to keep balance and to prevent external interferences.  
Nevertheless, similar to the multiple functions of other signaling systems,80 the 
endophytic signaling systems may also have extensive functions including awareness of 
population density, regulating secondary metabolites production, the formation of inner-
species or inter-species biofilm, dormancy, and competence as well as influencing the 
behavior of host plants. Comprehending these functions is crucial for us to exploit the 
potential of endophytes and reveal their ecological roles.  
3. Endophytes are rich resource of bioactive compounds 
Scientists have been aware of that endophytes are a bonanza of bioactive compounds 
for pharmaceutical development in the recent two decades, because many endophytes 
benefit host plant by producing bioactive secondary metabolites.35 Every year, there are 
many bioactive natural products reported from different microorganisms.294 Because of 
toxicity or non-selectivity, however, many bio-active compounds cannot be applied as 
clinical medicines. Whereas, these antibacterial azaphilones from Colletotrichum sp. 
BS4 showed ignorable cytotoxicity towards human cell line at the same order of 
magnitude of active concentration towards tested environmental bacteria, which could 
be interesting for further pharmaceutical investigation. This discovery also provides us 
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insights to consider the strategy of endophytes to produce bioactive compounds. In a 
balanced endophytic system, the defending factors produced by endophytes ought to be 
less toxic towards host plant cells and other endophytes than pathogens or predators. 
These special selective stress may be the driving force for endophytes to produce 
selective defending secondary metabolites, from which the possibility to discover 
promising drug lead might be higher than from other origins. For example, cytotoxic and 
antimicrobial maytansine was determined to be produced by the endophytic bacterial 
community harbored in the roots of Putterlickia plants, which obviously has an impact on 
other coexisting organisms.54,67 However, host plant cells and the endophytic bacterial 
community of the plant are immune to the toxicity of maytansine over an evolutionary 
period.54  
4. Perspectives for investigating secondary metabolites of 
endophytes 
There are many well-established chemical or biological techniques in recent years, 
including genome mining and genetic modification, biosynthetic pathways engineering in 
heterologous organisms, and direct utilization of enzymes to synthesize target 
compounds.67 However, many bottlenecks still need to be overcome to investigate 
endophytes comprehensively. For example, the relevant biosynthetic pathway of 
paclitaxel has not been successfully constructed correctly in heterologous hosts, 
because the mechanism of several key biosynthetic steps is still not clear.63  
Moreover, discerning fermentation methods employing strategies like OSMAC,255 dual 
and multiple/mixed cultures295 can hardly introduce the natural triggers into artificial 
conditions or mimic the natural endophytic environment.67 The reason is that the 
endophytic communities consist of many other cryptic microorganisms (including 
endophytes besides bacteria and fungi, for example, endophytic viruses) that are 
influenced by an enormous number of ambient factors.67,296  
Presently, the in situ approaches used to investigate uncultured microorganisms may 
provide useful clues to reconstruct the natural conditions for endophytes in the 
laboratory,67,219 which might enable us to figure out the reason why some endophytes 
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stop producing these interesting compounds. Furthermore, in this case, the application 
of IMS exemplified a strategy to visualize, both spatially and temporally, the chemical 
communication between endophytes (fungi and bacteria), and discover important 
secondary metabolites at low physiological concentrations and in a short available 
window (because of gradual degeneration of endophytes in artificial conditions). IMS 
technology also allows us to visualize the functional compounds produced by 
endophytes in plant tissues directly.54 With these approaches, future investigation of 
natural products ought to connect bioactive compounds with their ecological functions, 
rather than only document their structures and bioactivities.  
Despite the high sensitivity of MS technology for detecting microbial secondary 
metabolites, the structures of complex compounds with many isomers cannot be 
satisfactorily elucidated merely by MS or MSn. To elucidate natural products besides 
peptides, such as terpenoids and polyketides, conventional purification and 
characterization by other technologies (including 1D and 2D NMR, X-ray diffraction) are 
indispensable. Therefore, these unknown compounds with only traceable amount 
(insufficient for NMR or X-ray diffraction analysis) can barely be fully elucidated by 
current technologies.  
With sufficient pure compounds, however, wrong structural assignments of natural 
products are still very common,192,193 even though scientists had X-ray diffraction data in 
some cases.297–299 In the structure elucidation of compounds 11, 13 and 15, different 
quantum chemical methods including ECD, structural geometry, and NMR property 
calculations were employed to assign the relative configuration or the planar structure, 
which is difficult to be solved by other conventional technologies. As many other cases 
reported in literature,300–303 it is compelling that the combination of many other innovative 
technologies will be routine strategy for structural elucidation.  
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Figure S1 1H NMR (500 MHz, D2O) of α-deuterium-leucine 
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Figure S2 1H NMR (500 MHz, D2O) of α-deuterium-isoleucine 
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Figure S3 1H NMR (500 MHz, D2O) of α-deuterium-valine 
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Figure S4 1H NMR (500 MHz, D2O) of α-deuterium-alanine 
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Figure S5 1H NMR (500 MHz, D2O) of α-deuterium-proline 
 
Chapter 8: Supplemental data 
 
124 
 
Figure S6 1H NMR (500 MHz, D2O) of 2,4,4,4-tetradeuterium-threonine 
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Figure S7 1H NMR (500 MHz, CDCl3) of N-Boc-4-OH-4-deuterium-L-proline methyl ester 
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Figure S8 1H NMR (500 MHz, D2O) of 4-OH-4-deuterium-L-proline methyl ester 
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Figure S9 The ESI-HRMS (positive) of 2,4,4,4-tetradeuterium-threonine 
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Figure S10 MS2 (positive) of compounds 1−9 in FTMS mode (CID 35 eV) 
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Figure S11 The LC-MS analysis for hexacyclopeptides in fermented static PDB inoculated 
from different seed plates.  
  
Second generation seed plate, 10 days 
Second generation seed plate, 40 days 
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Figure S12 The interferences on blank agar with matrix solution for MALDI-IMS measurement 
(∆ < 2 ppm) 
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Figure S13 The MS3 (positive) of isoleucine (C6H13NO2). 
Parent ions: m/z 132.1, [M+H]+ for MS2 and m/z 86.1, [M-HCOOH+H]+ for MS3 (isolation 
width: m/z 2 amu). 
  
Chapter 8: Supplemental data 
 
132 
 
Figure S14 . 1H NMR (500 MHz, CD3OD) spectrum of colletotrichone A (10) 
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Figure S15 13C NMR (125 MHz, CD3OD) spectrum of colletotrichone A (10) 
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Figure S16 HSQC (500 MHz, CD3OD) spectrum of colletotrichone A (10) 
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Figure S16 HSQC (500 MHz, CD3OD) spectrum of colletotrichone A (10) 
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Figure S17 HMBC (500 MHz, CD3OD) spectrum of colletotrichone A (10) 
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Figure S17 HMBC (500 MHz, CD3OD) spectrum of colletotrichone A (10) 
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Figure S18 Positive ESIHRMS of colletotrichone A (10) 
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Figure S19 1H NMR (500 MHz, CDCl3) spectrum of colletotrichone B (11a) 
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Figure S20 13C NMR (125 MHz, CDCl3) spectrum of colletotrichone B (11a) 
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Figure S21 HSQC (500 MHz, CDCl3) spectrum of colletotrichone B (11a) 
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Figure S21 HSQC (500 MHz, CDCl3) spectrum of colletotrichone B (11a) 
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Figure 22 HMBC (500 MHz, CDCl3) spectrum of colletotrichone B (11a) 
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Figure S22 HMBC (500 MHz, CDCl3) spectrum of colletotrichone B (11a) 
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Figure S23 1H, 1H COSY (500 MHz, CDCl3) spectrum of colletotrichone B (11a) 
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Figure S24 1D NOESY (500 MHz, CDCl3) spectrum of colletotrichone B (11a)     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 8: Supplemental data 
 
147 
 
Figure S25 1H NMR (500 MHz, acetone-d6) spectrum of colletotrichone B (11a) 
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Figure S26 13C NMR (125 MHz, acetone-d6) spectrum of colletotrichone B (11a) 
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Figure S27 HSQC (500 MHz, acetone-d6) spectrum of colletotrichone B (11a) 
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Figure S28 HMBC (500 MHz, acetone-d6) spectrum of colletotrichone B (11a) 
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Figure S29 1H, 1H COSY (500 MHz, acetone-d6) spectrum of colletotrichone B (11a) 
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Figure S30 NOESY (500 MHz, acetone-d6) spectrum of colletotrichone B (11a) 
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Figure S30 NOESY (500 MHz, acetone-d6) spectrum of colletotrichone B (11a) 
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Figure S31 1D NOESY (500 MHz, acetone-d6) spectrum of colletotrichone B (11a) 
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Figure S31 1D NOESY (500 MHz, acetone-d6) spectrum of colletotrichone B (11a) 
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Figure S32 Positive ESIHRMS of colletotrichone B (11a) 
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Table S1. Experimental 13C NMR data (CDCl3) of colletotrichone B (11a) and calculated 
13C NMR dataa of compounds 
11a/11b/11c/11d  
Atom No. Exp data of 
11a 
Cacld 11a 
(6R,7R,10R,12
S) 
Abs deviation Cacld 11b 
(6R,7R,10S,12
R) 
Abs deviation Cacld 11c 
(6R,7R,10R,12
R) 
Abs deviation Cacld 11d 
(6R,7R,10S,12
S) 
Abs 
deviation 
1 147.2 146.84 0.36 147.08 0.12 147.15 0.05 147.60 0.40 
2 159.4 157.51 1.89 158.25 1.15 157.97 1.43 158.52 0.88 
3 107.3 109.37 2.07 110.75 3.45 110.47 3.17 110.68 3.38 
4 105.8 107.40 1.60 108.05 2.25 107.06 1.26 108.45 2.65 
5 191.5 189.83 1.67 190.62 0.88 189.99 1.51 191.62 0.12 
6 83.2 80.72 2.48 81.88 1.32 80.50 2.70 81.81 1.39 
7 43.0 42.42 0.58 48.72 5.72 42.27 0.73 48.90 5.90 
8 114.6 117.26 2.66 116.72 2.12 118.05 3.45 116.56 1.96 
9 144.5 138.69 5.81 142.61 1.89 140.14 4.36 142.55 1.95 
10 55.7 56.59 0.89 59.44 3.74 55.48 0.22 59.65 3.95 
11 206.3 213.03 6.73 207.09 0.79 212.45 6.15 210.39 4.09 
12 46.6 45.67 0.93 47.58 0.98 46.47 0.13 47.48 0.88 
13 26.2 29.11 2.91 27.83 1.63 25.09 1.11 27.96 1.76 
14 11.1 12.00 0.90 13.31 2.21 12.08 0.98 12.00 0.90 
15 19.5 18.18 1.32 19.12 0.38 19.18 0.32 19.12 0.38 
16 23.2 22.70 0.50 24.75 1.55 23.82 0.62 24.85 1.65 
17 14.1 15.35 1.25 15.77 1.67 16.31 2.21 18.74 4.64 
18 168.6 167.58 1.02 170.77 2.17 167.85 0.75 170.61 2.01 
a The conformer distributions of the molecules in question were searched in a systematic approach with the MMFF routine of Spartan'14 
(Wavefunction, Inc.: Irvine, CA, 2014).
8
 The geometries of all resulting conformers within an energy range of < 25 kJ/mol above the global minimum 
were then optimized, first with HF/3-21G and then within < 15 kJ/mol by DFT using the wB97X-D functional and the 6-31G* basis set. The resulting 
geometries with preliminary Boltzmann factors > 0.001 were used without further geometry optimization to calculate the NMR spectra with EDF2/6-
31G*; SPARTAN's corrected shifts were used without further solvent corrections (the solvent model is not yet provided in Spartan’14) . The final 
Boltzmann factors were obtained with wB97XD/6-311+G(2df,2p), using Gaussian g09.
9
 The NMR shifts of all remaining conformers were averaged 
with respect to their final Boltzmann factors. 
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Table S2 Comparison of 1H and 13C NMR spectroscopic data for compounds 11a, monochaetin (14b),a 3, and chermesinone 
B (14a)a (CDCl3)  
Position 11a Monochaetin (14b) 12 Chermesinone B (14a) 
δC δH mult. (J in Hz) δC δH mult. (J in Hz) δC δH mult. (J in Hz) δC δH mult. (J in Hz) 
1 147.2 7.30, 1H, s 143.3 6.79, dd (1.9, 1.3 ) 69.0 3.95, 1H, dd (11.5, 5.4) 
3.84, 1H, dd (13.5, 
11.5) 
143.5 6.83, s 
2 159.4  158.5  163.9  158.8  
3 107.3 6.00, 1H, s 107.0 6.02, q ( < 0.4) 101.1 5.48, 1H, br s 107.3 6.05, s 
4 105.8 5.36, 1H, br s 105.7 5.29, d (1.3) 115.0 5.62, 1H, br s 106.1 5.34, d (0.8) 
5 191.5  191.8  192.5  192.1  
6 83.2  82.6  83.4  82.8  
7 43.0 3.89, 1H, br s 43.7 3.76, dd (12.8, 1.9) 44.5 3.10, 1H, dd (12.5, 
11.5) 
43.8 3.81, dd (12.9, 1.9) 
8 114.6  116.2  35.6 2.74, 1H, 
dddd (13.5, 11.5, 5.4, 
1.5) 
116.5  
9 144.5  145.5  153.0  145.7  
10 55.7 3.89, 1H, br s 52.1 4.05, d (12.8) 52.6 3.93, 1H, d (12.5) 51.7 4.09, d (12.9) 
11 206.3  205.9  206.2  206.2  
12 46.6 3.10, 1H, m 46.7 3.19, qdd (6.7, 7.4, 5.4) 47.8 3.07, 1H, m 47.3 3.15, m 
13 26.2 1.60, 1H, m 
1.37, 1H, m 
26.3 1.81, qdd (7.4, 13.0, 
5.4) 
1.48, qdd (7.4, 13.0, 
7.4) 
24.5 1.79, 1H, m 
1.42, 1H, m 
25.1 1.80, m 
1.43, m 
14 11.1 0.81, 3H, t (7.4) 11.5 0.97, t (7.4) 11.5 0.90, 3H, t (7.5) 11.7 0.90, t (7.4) 
15 19.5 2.14, 3H, s 19.5 2.13, d ( < 0.4) 20.6 1.95, 3H, s 19.8 2.17, s 
16 23.2 1.57, 3H, s 18.9 1.32, s 18.8 1.50, 3H, s 19.1 1.36, s 
17 14.1 1.09, 3H, d (6.5) 14.4 1.11, d (6.7) 16.7 1.19, 3H, d (7.2) 17.1 1.24, d (7.1) 
18 168.6  169.1  168.8  169.3  
a
 Adapted from the Supporting Information of Huang et al. (2011).
7
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Figure S331H NMR (500 MHz, CDCl3) spectrum of colletotrichone C (12) 
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Figure S34 13C NMR (125 MHz, CDCl3) spectrum of colletotrichone C (12) 
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Figure S35 HSQC (500 MHz, CDCl3) spectrum of colletotrichone C (12) 
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Figure S35 HSQC (500 MHz, CDCl3) spectrum of colletotrichone C (12) 
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Figure S36 HMBC (500 MHz, CDCl3) spectrum of colletotrichone C (12) 
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Figure S36 HMBC (500 MHz, CDCl3) spectrum of colletotrichone C (12) 
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Figure S37 1H, 1H COSY (500 MHz, CDCl3) spectrum of colletotrichone C (12) 
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Figure S37 1H, 1H COSY (500 MHz, CDCl3) spectrum of colletotrichone C (12) 
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Figure S38 NOESY (500 MHz, CDCl3) spectrum of colletotrichone C (12) 
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Figure S38 NOESY (500 MHz, CDCl3) spectrum of colletotrichone C (12) 
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Figure S39 Positive ESIHRMS of colletotrichone C (12) 
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Figure S40 Interference signals of target mass weights on blank control of rice agar 
        
                                                                                               
           Target mass weight, m/z 387.0840613, ∆ = 1 ppm                     Target mass weight, m/z 355.0942321, ∆ = 1 ppm 
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Figure S41 1H NMR (500 MHz, CDCl3) spectrum of colletotrichone D (13) 
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Figure S42 13C NMR (125 MHz, CDCl3) spectrum of colletotrichone D (13) 
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Figure S43 HSQC of spectrum colletotrichone D (13) 
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Figure S44 HMBC of spectrum colletotrichone D (13) 
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Figure S44 HMBC of spectrum colletotrichone D (13) 
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Figure S45 1D NOESY (500 MHz, CDCl3) spectrum of colletotrichone D (13) 
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Figure S45 1D NOESY (500 MHz, CDCl3) spectrum of colletotrichone D (13) 
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Figure S45 1D NOESY (500 MHz, CDCl3) spectrum of colletotrichone D (13) 
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Figure S46 1H NMR (500 MHz, acetone-d6) spectrum of phyllostictalactam A (15) 
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Figure S47. 13C NMR (125 MHz, acetone-d6) spectrum of phyllostictalactam A (15) 
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Figure S48 HSQC (500 MHz, acetone-d6) spectrum of phyllostictalactam A (15) 
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Figure S49 HMBC (500 MHz, acetone-d6) spectrum of phyllostictalactam A (15) 
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Figure S50 ESI-HRMS of phyllostictalactam A (15) 
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Figure S51 MS2 of phyllostictalactam A (15) (parent mass: 266.1024, [M+H]+, CID energy: 35 eV) 
 
BS53-MS2 #1609-1714 RT: 13.28-13.98 AV: 106 NL: 2.34E7
T: FTMS + c ESI Full ms2 266.10@cid35.00 [70.00-270.00]
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Figure S52 MS3 of phyllostictalactam A (15) (parent mass: 249.0757 from MS2, CID energy: 35 eV) 
 
BS53-MS3 #1135-1194 RT: 13.31-13.84 AV: 15 NL: 7.36E6
T: FTMS + c ESI Full ms3 266.10@cid35.00 249.10@cid35.00 [65.00-270.00]
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Figure S53. 1H NMR (500 MHz, acetone-d6) spectrum of phyllostictalactam B (16) 
 
EtOAc 
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Figure S54 HSQC (500 MHz, acetone-d6) spectrum of phyllostictalactam B (16) 
 
Chapter 8: Supplemental data 
 
188 
 
Figure S55 ESIHRMS of phyllostictalactam B (16) 
  
BS53-dehydrated2 #983-1030 RT: 16.47-17.19 AV: 48 NL: 9.72E6
T: FTMS + c ESI Full ms [200.00-1000.00]
245 250 255 260 265 270 275 280 285
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
248.0917
C 13 H14 O 4 N
-0.3319 ppm
265.1182
C 13 H17 O 4 N2
-0.4589 ppm
280.1178
C 12 H21 O 3 N2 K
-2.0991 ppm
Chapter 8: Supplemental data 
 
189 
 
Figure S56 LC-MS of synthesized phyllostictalactam B (16) and crude extracts 
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Figure S57 MS2 spectrum of phyllostictalactam B (16) (parent mass: 248.0917, CID energy: 35 eV) 
BS53-dehydrated2-MS2 #1218-1259 RT: 16.48-16.96 AV: 42 NL: 2.13E6
T: FTMS + c ESI Full ms2 248.09@cid35.00 [65.00-255.00]
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List of abbreviations 
Full name Abbreviation 
BP Base pairs 
Collisionally activated dissociation CAD 
Collisionally-induced dissociation CID 
Double bond equivalent DBE 
Desorption electrospray ionization DESI 
Dilution factor DF 
Density functional theory DFT 
Desorption/ionization on silicon mass spectrometry  DIOS MS 
Deoxyribonucleic acid DNA 
Deoxynucleoside triphosphate dNTP 
Ethyl acetate EtOAc 
Formic acid FA 
Fourier transform mass spectrometry FTMS 
Fractional survival FS 
Gauge-including atomic orbitals GIAO 
Imaging mass spectrometry IMS 
α-Cyano-4-hydroxycinnamic acid HCCA 
Liquid chromatography-high resolution mass spectrometry LC-HRMS 
Liquid micro-junction surface sampling probe LMJ-SSP 
Limit of detection LOD 
Mean absolute deviation MAD 
Mean absolute error MAE 
Matrix-assisted laser desorption/ionization MALDI 
Mass spectrometry MS 
Tandem mass spectrometry MS/MS 
Multiple-stage mass spectrometry MSn 
Multiple standard method MTSD 
Nutrient agar NA 
Nutrient broth NB 
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Nuclear Overhauser effects NOE 
Nuclear Overhauser effect spectroscopy NOESY 
Nonribosomal peptides NRP  
Nonribosomal peptide synthetase NRPS 
One Strain Many Compounds OSMAC 
Phosphate-buffered saline PBS 
Polymerase chain reaction PCR 
Potato dextrose agar PDA (medium) 
Photodiode array detector PDA (detector) 
Potato dextrose broth PDB 
Polyketide synthase PKS 
Plant natural products PNP 
Quorum sensing QS 
Root mean square RMS 
Room temperature R. t. 
Retention time R. t. 
Sabouraud dextrose agar SDA 
Traditional Chinese medicine TCM 
Total ion current TIC 
Trifluoroacetic acid TFA 
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